反馈咨询
欢迎添加微信!
微信号:z_gqing
微信二维码:
扫公众号
期刊文献 > Front Immunol期刊 选择月份
2023 Sep (26)
2023 Aug (438)
2023 Jul (435)
2023 Jun (462)
2023 May (575)
2023 Apr (458)
2023 Mar (653)
2023 Feb (325)
2023 Jan (501)
2022 Dec (301)
2022 Nov (318)
2022 Oct (348)
2022 Sep (406)
2022 Aug (366)
2022 Jul (405)
2022 Jun (315)
2022 May (306)
2022 Apr (255)
2022 Mar (301)
2022 Feb (298)
2022 Jan (301)
2021 Dec (255)
2021 Nov (262)
2021 Oct (261)
2021 Sep (243)
2021 Aug (221)
2021 Jul (225)
2021 Jun (286)
2021 May (249)
2021 Apr (250)
2021 Mar (252)
2021 Feb (289)
2021 Jan (149)
1. Immunization with Tp0954, an adhesin of Treponema pallidum, provides protective efficacy in the rabbit model of experimental syphilis.
Front Immunol
2023 Mar 9
He Y, Chen D, Fu Y
2. Differentiation-related genes in tumor-associated macrophages as potential prognostic biomarkers in non-small cell lung cancer.
Front Immunol
2023 Mar 9
Li Z, Zhou B, Zhu X
3. Knowledge mapping of autophagy in osteoarthritis from 2004 to 2022: A bibliometric analysis.
Front Immunol
2023 Mar 9
Liao J, Yu X, Chen J
4. An emerging role of inflammasomes in spinal cord injury and spinal cord tumor.
Front Immunol
2023 Mar 9
Chen J, Shen Y, Shao X
5. Model-interpreted outcomes of artificial neural networks classifying immune biomarkers associated with severe infections in ICU.
Front Immunol
2023 Mar 9
Martinez GS, Ostadgavahi AT, Al-Rafat AM
6. Peripheral blood mononuclear cells reactivity in recent-onset type I diabetes patients is directed against the leader peptide of preproinsulin, GAD65(271-285) and GAD65(431-450).
Front Immunol
2023 Mar 9
Jores RD, Baldera D, Schirru E
7. B cell targeted therapies in inflammatory autoimmune disease of the central nervous system.
Front Immunol
2023 Mar 9
Furman MJ, Meuth SG, Albrecht P
8. Immunomodulation-a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system.
Front Immunol
2023 Mar 9
Strzelec M, Detka J, Mieszczak P
9. Integrating microbiome and metabolome revealed microbe-metabolism interactions in the stomach of patients with different severity of peptic ulcer disease.
Front Immunol
2023 Mar 9
Wang C, Yu X, Lin H
10. Impact of oral microbiota on pathophysiology of GVHD.
Front Immunol
2023 Mar 9
Yamamoto A, Kambara Y, Fujiwara H.
11. Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature.
Front Immunol
2023 Mar 9
Habibi A, Zarei-Behjani Z, Falamarzi K
12. Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis.
Front Immunol
2023 Mar 9
Zhang J, Zhang Y, Yang Z
13. CD27(+) microparticle interactions and immunoregulation of CD4(+) T lymphocytes.
Front Immunol
2023 Mar 9
Cagnet L, Neyrinck-Leglantier D, Tamagne M
14. Porcine anti-human lymphocyte immunoglobulin depletes the lymphocyte population to promote successful kidney transplantation.
Front Immunol
2023 Mar 9
Zhang L, Zou H, Lu X
15. A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.
Front Immunol
2023 Mar 9
Carter B, Huang P, Liu G
16. A cis-element at the Rorc locus regulates the development of type 3 innate lymphoid cells.
Front Immunol
2023 Mar 9
Chang D, Zhang H, Ge J
17. Lacticaseibacilli attenuated fecal dysbiosis and metabolome changes in Candida-administered bilateral nephrectomy mice.
Front Immunol
2023 Mar 9
Chancharoenthana W, Kamolratanakul S, Visitchanakun P
18. Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response.
Front Immunol
2023 Mar 9
Agrati C, Bartolini B, Bordoni V
19. Immunogenicity and protective efficacy of OmpA subunit vaccine against Aeromonas hydrophila infection in Megalobrama amblycephala: An effective alternative to the inactivated vaccine.
Front Immunol
2023 Mar 9
Zhang M, Zhang T, He Y
20. Tissue-resident memory T cells in gastrointestinal tumors: turning immune desert into immune oasis.
Front Immunol
2023 Mar 9
Liang M, Wang X, Cai D
21. Identification of immune-related genes in diagnosing atherosclerosis with rheumatoid arthritis through bioinformatics analysis and machine learning.
Front Immunol
2023 Mar 9
Liu F, Huang Y, Liu F
22. Transcription factors in megakaryocytes and platelets.
Front Immunol
2023 Mar 9
Yuan H, Liu Y, Zhang J
23. Oral route lipopolysaccharide as a potential dementia preventive agent inducing neuroprotective microglia.
Front Immunol
2023 Mar 9
Mizobuchi H.
24. Immunomodulatory function and anti-tumor mechanism of natural polysaccharides: A review.
Front Immunol
2023 Mar 9
Ying Y, Hao W.
25. Causal relationships between gut microbiota and programmed cell death protein 1/programmed cell death-ligand 1: A bidirectional Mendelian randomization study.
Front Immunol
2023 Mar 9
Huang YF, Zhang WM, Wei ZS
26. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative.
Front Immunol
2023 Mar 9
Bonilla H, Peluso MJ, Rodgers K
27. Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer.
Front Immunol
2023 Mar 9
Lian B, Chen X, Shen K.
28. Insights into the cellular pathophysiology of familial hemophagocytic lymphohistiocytosis.
Front Immunol
2023 Mar 9
Steen EA, Nichols KE, Meyer LK.
29. Dendritic cell expression of CD24 contributes to optimal priming of T lymphocytes in lymph nodes.
Front Immunol
2023 Mar 9
Zhang X, Yu C, Liu JQ
30. Microbiota-ear-brain interaction is associated with generalized anxiety disorder through activation of inflammatory cytokine responses.
Front Immunol
2023 Mar 9
Feng R, Zhu Q, Li Q
31. Case report: Mucous membrane pemphigoid with complicated autoantibody profile indicating the necessity of comprehensive diagnostic methods and the contribution of IgA autoantibodies.
Front Immunol
2023 Mar 9
Liu W, Li H, Jin Y
32. Release of exosomes in polytraumatized patients: The injury pattern is reflected by the surface epitopes.
Front Immunol
2023 Mar 9
Weber B, Henrich D, Schindler CR
33. Meningoencephalitis associated with GAD65 autoimmunity.
Front Immunol
2023 Mar 9
Kuang Z, Baizabal-Carvallo JF, Mofatteh M
34. Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy.
Front Immunol
2023 Mar 9
Lin C, Wang N, Xu C.
35. Antibody response to different COVID-19 vaccines among the migrant workers of Bangladesh.
Front Immunol
2023 Mar 9
Hossain MI, Sarker P, Raqib R
36. The causality between intestinal flora and allergic diseases: Insights from a bi-directional two-sample Mendelian randomization analysis.
Front Immunol
2023 Mar 9
Jin Q, Ren F, Dai D
37. Dietary supplementation of coated sodium butyrate improves growth performance of laying ducks by regulating intestinal health and immunological performance.
Front Immunol
2023 Mar 9
Zeng T, Sun H, Huang M
38. The prognostic and immune significance of C15orf48 in pan-cancer and its relationship with proliferation and apoptosis of thyroid carcinoma.
Front Immunol
2023 Mar 9
Li C, Tang Y, Li Q
39. Are IL-1 family cytokines important in management of sickle cell disease in Sub-Saharan Africa patients?
Front Immunol
2023 Mar 9
Siransy LK, Dasse RS, Adou H
40. TOX regulates T lymphocytes differentiation and its function in tumor.
Front Immunol
2023 Mar 9
Niu H, Wang H.
41. Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1β release by mononuclear phagocytes.
Front Immunol
2023 Mar 9
Richter K, Asci N, Singh VK
42. Enriched environment remodels the central immune environment and improves the prognosis of acute ischemic stroke in elderly mice with chronic ischemia.
Front Immunol
2023 Mar 9
Zhang S, Zhang Y, Liu H
43. The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential.
Front Immunol
2023 Mar 9
Zhu MH, Liu YJ, Li CY
44. Transcriptional control of ILC identity.
Front Immunol
2023 Mar 9
Korchagina AA, Shein SA, Koroleva E
45. Role of regulation of PD-1 and PD-L1 expression in sepsis.
Front Immunol
2023 Mar 9
Zhang T, Yu-Jing L, Ma T.
46. Socs3b regulates the development and function of innate immune cells in zebrafish.
Front Immunol
2023 Mar 8
Sobah ML, Scott AC, Laird M
47. Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study.
Front Immunol
2023 Mar 8
Yan Q, Zhang M, Du F
48. MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression.
Front Immunol
2023 Mar 8
Schrörs B, Hos BJ, Yildiz IG
49. Erratum: Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation.
Front Immunol
2023 Mar 8
Frontiers Production Office.
50. The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus.
Front Immunol
2023 Mar 8
Wang B, Chen C, Liu X
51. Identification of a novel immune landscape signature as effective diagnostic markers related to immune cell infiltration in diabetic nephropathy.
Front Immunol
2023 Mar 8
Zhou H, Mu L, Yang Z
52. Human intestinal epithelial cells can internalize luminal fungi via LC3-associated phagocytosis.
Front Immunol
2023 Mar 8
Cohen-Kedar S, Shaham Barda E, Rabinowitz KM
53. Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status.
Front Immunol
2023 Mar 8
Aissatou A, Fokam J, Semengue ENJ
54. Effect of postoperative systemic prednisolone on short-term and long-term outcomes in chronic rhinosinusitis with nasal polyps: A multi-centered randomized clinical trial.
Front Immunol
2023 Mar 8
Mueller SK, Wendler O, Mayr S
55. Identification of risk factors for elevated serum IgG4 levels in subjects in a large-scale health checkup cohort study.
Front Immunol
2023 Mar 8
Tsuji Y, Koga T, Nonaka F
56. Extracellular vesicles and their cells of origin: Open issues in autoimmune diseases.
Front Immunol
2023 Mar 8
Haghighitalab A, Dominici M, Matin MM
57. Labour promotes systemic mobilisation of monocytes, T cell activation and local secretion of chemotactic factors in the intervillous space of the placenta.
Front Immunol
2023 Mar 8
Vikberg S, Lindau R, Solders M
58. Integrative bioinformatics analysis to identify novel biomarkers associated with non-obstructive azoospermia.
Front Immunol
2023 Mar 8
Zhong Y, Zhao J, Deng H
59. Inflammasome and pyroptosis in autoimmune liver diseases.
Front Immunol
2023 Mar 8
Wang J, Sun Z, Xie J
60. Efficacy and safety of TCMs with anti-inflammatory effect in patients with rheumatoid arthritis: A network meta-analysis.
Front Immunol
2023 Mar 8
Fang J, Liu M, Huang Z
61. Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders.
Front Immunol
2023 Mar 8
Denis J, Garnier A, Cheutin L
62. Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19.
Front Immunol
2023 Mar 8
Martínez-Diz S, Marín-Benesiu F, López-Torres G
63. Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus.
Front Immunol
2023 Mar 8
Korn MA, Steffensen M, Brandl C
64. Integrated bioinformatics analysis identifies shared immune changes between ischemic stroke and COVID 19.
Front Immunol
2023 Mar 8
Liu W, Han F, Wan M
65. In-situ tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy.
Front Immunol
2023 Mar 8
Kim NJ, Yoon JH, Tuomi AC
66. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.
Front Immunol
2023 Mar 8
Ancona G, Alagna L, Alteri C
67. The Peptidyl-Prolyl cis-trans isomerase, Pin1, associates with Protein Kinase C θ via a critical Phospho-Thr-Pro motif in the V3 regulatory domain.
Front Immunol
2023 Mar 8
Anto NP, Muraleedharan A, Nath PR
68. Associations between bullous pemphigoid and hematological diseases: Literature review on mechanistic connections and possible treatments.
Front Immunol
2023 Mar 8
Yang Y, Zhao W, Yang N
69. Targeting RIPK1 kinase for modulating inflammation in human diseases.
Front Immunol
2023 Mar 8
Li W, Yuan J.
70. Study of the shared gene signatures of polyarticular juvenile idiopathic arthritis and autoimmune uveitis.
Front Immunol
2023 Mar 8
Zheng J, Wang Y, Hu J.
71. Erratum: Alkaline phosphatase combined with γ-glutamyl transferase is an independent predictor of prognosis of hepatocellular carcinoma patients receiving programmed death-1 inhibitors.
Front Immunol
2023 Mar 8
Frontiers Production Office.
72. Macrophages in aseptic loosening: Characteristics, functions, and mechanisms.
Front Immunol
2023 Mar 8
Cong Y, Wang Y, Yuan T
73. Integrated analysis of cell-specific gene expression in peripheral blood using ISG15 as a marker of rejection in kidney transplantation.
Front Immunol
2023 Mar 8
Zhang Z, Qin Y, Wang Y
74. Analyses of thymocyte commitment to regulatory T cell lineage in thymus of healthy subjects and patients with 22q11.2 deletion syndrome.
Front Immunol
2023 Mar 8
Borna S, Dejene B, Lakshmanan U
75. Humanized MISTRG as a preclinical in vivo model to study human neutrophil-mediated immune processes.
Front Immunol
2023 Mar 8
Martinez-Sanz P, Laurent ARG, Slot E
76. Differential regulatory T cell signature after recovery from mild COVID-19.
Front Immunol
2023 Mar 8
de Sousa Palmeira PH, Peixoto RF, Csordas BG
77. Predictors of cardiac involvement in idiopathic inflammatory myopathies.
Front Immunol
2023 Mar 8
Bandeira M, Dourado E, Melo AT
78. Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis.
Front Immunol
2023 Mar 8
Zhao Y, Deng Y, Jiang Y
79. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
Front Immunol
2023 Mar 8
Cui H, Ren X, Dai L
80. Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population.
Front Immunol
2023 Mar 8
Kawasaki A, Sada KE, Kusumawati PA
81. Regulation of CD8 T cell by B-cells: A narrative review.
Front Immunol
2023 Mar 8
Van Meerhaeghe T, Néel A, Brouard S
82. Metabolic regulation of dendritic cell activation and immune function during inflammation.
Front Immunol
2023 Mar 8
Wu L, Yan Z, Jiang Y
83. Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro.
Front Immunol
2023 Mar 8
Zekri L, Ruetalo N, Christie M
84. Roles and therapeutic implications of m6A modification in cancer immunotherapy.
Front Immunol
2023 Mar 7
Pan J, Huang T, Deng Z
85. The prognostic significance of human ovarian aging-related signature in breast cancer after surgery: A multicohort study.
Front Immunol
2023 Mar 7
Hua X, Zhu QW, Zhang YN
86. cGAS-dependent proinflammatory and immune homeostatic effects of the microtubule-targeting agent paclitaxel.
Front Immunol
2023 Mar 7
Serpico AF, Pisauro C, Grieco D.
87. Diversity of immune checkpoints in cancer immunotherapy.
Front Immunol
2023 Mar 7
Guo Z, Zhang R, Yang AG
88. Inhibiting efferocytosis reverses macrophage-mediated immunosuppression in the leukemia microenvironment.
Front Immunol
2023 Mar 7
Cruz Cruz J, Allison KC, Page LS
89. Cladribine treatment specifically affects peripheral blood memory B cell clones and clonal expansion in multiple sclerosis patients.
Front Immunol
2023 Mar 7
Ruschil C, Gabernet G, Kemmerer CL
90. Surfactant protein A alters endosomal trafficking of influenza A virus in macrophages.
Front Immunol
2023 Mar 7
Yau E, Yang L, Chen Y
91. Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk.
Front Immunol
2023 Mar 7
Hewavisenti RV, Arena J, Ahlenstiel CL
92. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.
Front Immunol
2023 Mar 7
Ljungman P, Tridello G, Piñana JL
93. Pharmacological potential of Withania somnifera (L.) Dunal and Tinospora cordifolia (Willd.) Miers on the experimental models of COVID-19, T cell differentiation, and neutrophil functions.
Front Immunol
2023 Mar 7
Rizvi ZA, Babele P, Madan U
94. T lymphocyte characteristics and immune repertoires in the epicardial adipose tissue of heart failure patients.
Front Immunol
2023 Mar 7
Zhang XZ, Chen XL, Tang TT
95. Phase 1 pilot study of RRx-001 + nivolumab in patients with advanced metastatic cancer (PRIMETIME).
Front Immunol
2023 Mar 7
Reid T, Oronsky B, Caroen S
96. Loss of CD28 expression associates with severe T-cell exhaustion in acute myeloid leukemia.
Front Immunol
2023 Mar 7
Huang Y, Zheng H, Zhu Y
97. Blood cell counts can predict adverse events of immune checkpoint inhibitors: A systematic review and meta-analysis.
Front Immunol
2023 Mar 7
Zhou J, Du Z, Fu J
98. Tumor-associated macrophages respond to chemotherapy by detrimental transcriptional reprogramming and suppressing stabilin-1 mediated clearance of EGF.
Front Immunol
2023 Mar 7
Larionova I, Kiselev A, Kazakova E
99. Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs.
Front Immunol
2023 Mar 7
Guilherme RF, Silva JBNF, Waclawiack I
100. PD-1 and CTLA-4 exert additive control of effector regulatory T cells at homeostasis.
Front Immunol
2023 Mar 7
Pereira JA, Lanzar Z, Clark JT
101. CARD11 gain-of-function mutation drives cell-autonomous accumulation of PD-1(+) ICOS(high) activated T cells, T-follicular, T-regulatory and T-follicular regulatory cells.
Front Immunol
2023 Mar 7
Masle-Farquhar E, Jeelall Y, White J
102. Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection.
Front Immunol
2023 Mar 7
Hyun H, Jang AY, Park H
103. The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer.
Front Immunol
2023 Mar 7
Zhao Z, Liu S, Sun R
104. Tissue specific imprinting on innate lymphoid cells during homeostasis and disease process revealed by integrative inference of single-cell transcriptomics.
Front Immunol
2023 Mar 7
Song P, Cao K, Mao Y
105. Degradation of collagen I by activated C1s in periodontal Ehlers-Danlos Syndrome.
Front Immunol
2023 Mar 7
Amberger A, Pertoll J, Traunfellner P
106. Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials.
Front Immunol
2023 Mar 7
McCarthy PM, Valdera FA, Smolinsky TR
107. Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic.
Front Immunol
2023 Mar 7
Sun Y, Luo B, Liu Y
108. Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factors.
Front Immunol
2023 Mar 6
Hu X, Wang L, Shang B
109. Characterization of a mutant samhd1 zebrafish model implicates dysregulation of cholesterol biosynthesis in Aicardi-Goutières syndrome.
Front Immunol
2023 Mar 6
Withers SE, Rowlands CF, Tapia VS
110. Transmission of Zika virus by dendritic cell subsets in skin and vaginal mucosa.
Front Immunol
2023 Mar 6
Eder J, Zijlstra-Willems E, Koen G
111. Erratum: Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation.
Front Immunol
2023 Mar 6
Frontiers Production Office.
112. Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study.
Front Immunol
2023 Mar 6
Manni S, Ruetsch C, Fabre R
113. Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?
Front Immunol
2023 Mar 6
Zhu J, Lian J, Xu B
114. Eosinophil and IFN-γ associated with immune-related adverse events as prognostic markers in patients with non-small cell lung cancer treated with immunotherapy.
Front Immunol
2023 Mar 6
Hu WT, Zhang Q, Zhang Z
115. Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments.
Front Immunol
2023 Mar 6
Chen S, Tang J, Liu F
116. Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing.
Front Immunol
2023 Mar 6
Xu D, Huang K, Chen Y
117. Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells.
Front Immunol
2023 Mar 6
Hiltensperger M, Krackhardt AM.
118. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
Front Immunol
2023 Mar 6
Nan H, Guo P, Fan J
119. Partial immune responses in Sichuan bream (Sinibrama taeniatus) after starvation.
Front Immunol
2023 Mar 6
Shi J, Zhuo D, Lu M
120. Construction and validation of chemoresistance-associated tumor- infiltrating exhausted-like CD8+ T cell signature in breast cancer: cr-TILCD8TSig.
Front Immunol
2023 Mar 6
Cai DQ, Cai D, Zou Y
121. Unraveling cross-reactivity of anti-glycan IgG responses in filarial nematode infections.
Front Immunol
2023 Mar 6
Petralia LMC, van Diepen A, Nguyen DL
122. Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents.
Front Immunol
2023 Mar 6
Leung D, Cohen CA, Mu X
123. Mass cytometry identifies characteristic immune cell subsets in bronchoalveolar lavage fluid from interstitial lung diseases.
Front Immunol
2023 Mar 6
Hata K, Yanagihara T, Matsubara K
124. Combining chemotherapy with CAR-T cell therapy in treating solid tumors.
Front Immunol
2023 Mar 6
Wang AX, Ong XJ, D'Souza C
125. PD-L1 expression as biomarker of efficacy of PD-1/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysis.
Front Immunol
2023 Mar 6
Khan M, Du K, Ai M
126. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
Front Immunol
2023 Mar 31
Zhu J, Wang D, Liu C
127. Autosomal recessive IL12RB1 mutation: A case report of a Sudanese child and his father.
Front Immunol
2023 Mar 31
Abdelmajeed O, Ali MMD, Erwa NH
128. C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates.
Front Immunol
2023 Mar 31
Vono M, Mastelic-Gavillet B, Mohr E
129. Interferon-β modulates microglial polarization to ameliorate delayed tPA-exacerbated brain injury in ischemic stroke.
Front Immunol
2023 Mar 31
Kuo PC, Weng WT, Scofield BA
130. Machine learning-based identification of tumor-infiltrating immune cell-associated model with appealing implications in improving prognosis and immunotherapy response in bladder cancer patients.
Front Immunol
2023 Mar 31
Chen H, Yang W, Ji Z.
131. Preoperative inflammatory markers predict postoperative clinical outcomes in patients undergoing heart valve surgery: A large-sample retrospective study.
Front Immunol
2023 Mar 31
Tian H, Jiang X, Duan G
132. Changes in risk factors for food sensitization in early life: Analysis over a period of 10 years.
Front Immunol
2023 Mar 31
Ma Z, Chen L, Xian R
133. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
Front Immunol
2023 Mar 31
Hua T, Liu DX, Zhang XC
134. Three-dimensional and single-cell sequencing of liver cancer reveals comprehensive host-virus interactions in HBV infection.
Front Immunol
2023 Mar 31
Guo M, Yao Z, Jiang C
135. An immune-related prognostic model predicts neoplasm-immunity interactions for metastatic nasopharyngeal carcinoma.
Front Immunol
2023 Mar 31
Chen X, Ding Q, Lin T
136. A close look at current γδ T-cell immunotherapy.
Front Immunol
2023 Mar 31
Ma L, Feng Y, Zhou Z.
137. Identifying TNF and IL6 as potential hub genes and targeted drugs associated with scleritis: A bio-informative report.
Front Immunol
2023 Mar 31
Yan F, Liu Y, Zhang T
138. Development of severe colitis is associated with lung inflammation and pathology.
Front Immunol
2023 Mar 31
Raftery AL, O'Brien CA, Harris NL
139. Staphylococcus aureus induces tolerance in human monocytes accompanied with expression changes of cell surface markers.
Front Immunol
2023 Mar 31
Müller MM, Baldauf C, Hornischer S
140. Biomarkers predicting clinical outcomes in nasopharyngeal cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis.
Front Immunol
2023 Mar 31
Qian X, Chen H, Tao Y.
141. TNFα aggravates detrimental effects of SARS-CoV-2 infection in the liver.
Front Immunol
2023 Mar 31
Lücke J, Nawrocki M, Schnell J
142. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
Front Immunol
2023 Mar 31
Zhao S, Ge Y, Li Z
143. Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients.
Front Immunol
2023 Mar 31
Körber N, Holzmann-Littig C, Wilkens G
144. Rational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction.
Front Immunol
2023 Mar 31
Shah M, Shin JY, Woo HG.
145. Uncovering a novel role of focal adhesion and interferon-gamma in cellular rejection of kidney allografts at single cell resolution.
Front Immunol
2023 Mar 31
Halawi A, El Kurdi AB, Vernon KA
146. Linking dysbiosis to precancerous stomach through inflammation: Deeper than and beyond imaging.
Front Immunol
2023 Mar 31
Lopes C, Almeida TC, Pimentel-Nunes P
147. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
Front Immunol
2023 Mar 31
Topczewska PM, Rompe ZA, Jakob MO
148. Phospholipase A and acyltransferase 4/retinoic acid receptor responder 3 at the intersection of tumor suppression and pathogen restriction.
Front Immunol
2023 Mar 31
Zhao JY, Yuan XK, Luo RZ
149. A four-part guide to lung immunology: Invasion, inflammation, immunity, and intervention.
Front Immunol
2023 Mar 31
Gopallawa I, Dehinwal R, Bhatia V
150. Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity.
Front Immunol
2023 Mar 31
Al Aameri RFH, Alanisi EMA, Oluwatosin A
151. Preclinical efficacy of oncolytic VSV-IFNβ in treating cancer: A systematic review.
Front Immunol
2023 Mar 31
Moglan AM, Albaradie OA, Alsayegh FF
152. Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome.
Front Immunol
2023 Mar 31
Tan Y, Liu Q, Li Z
153. Application of weighted gene co-expression network and immune infiltration for explorations of key genes in the brain of elderly COVID-19 patients.
Front Immunol
2023 Mar 31
Huang L, Qin W, Guo Z
154. Deep characterization of human γδ T cell subsets defines shared and lineage-specific traits.
Front Immunol
2023 Mar 31
Sanz M, Mann BT, Ryan PL
155. Maintenance and recall of memory T cell populations against tuberculosis: Implications for vaccine design.
Front Immunol
2023 Mar 31
Liu X, Li H, Li S
156. Regulation of microglia related neuroinflammation contributes to the protective effect of Gelsevirine on ischemic stroke.
Front Immunol
2023 Mar 30
Xing C, Lv J, Zhu Z
157. Bioinformatics-integrated screening of systemic sclerosis-specific expressed markers to identify therapeutic targets.
Front Immunol
2023 Mar 30
Jin J, Liu Y, Tang Q
158. PIK3C2A is a prognostic biomarker that is linked to immune infiltrates in kidney renal clear cell carcinoma.
Front Immunol
2023 Mar 30
Qin C, Liu S, Zhou S
159. Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity.
Front Immunol
2023 Mar 30
Maretti-Mira AC, Salomon MP, Hsu AM
160. Primary immunodeficiencies (PID) Life Index in Southeast Asia: A comparative analysis of PID Principles of Care (PoC).
Front Immunol
2023 Mar 30
Chan CM, Mahlaoui N, Sánchez Ramón S
161. Analysis of human lung mast cells by single cell RNA sequencing.
Front Immunol
2023 Mar 30
Rönnberg E, Ravindran A, Mazzurana L
162. Factors associated with knowledge and vaccination intention for human papillomavirus on trans girls by their main caregiver: A cross-sectional study.
Front Immunol
2023 Mar 30
Domínguez-Riscart J, Ariza-Jimenez AB, Baez-Castillo C
163. Functional plasticity of neutrophils after low- or high-dose irradiation in cancer treatment - A mini review.
Front Immunol
2023 Mar 30
Hu J, Pan M, Wang Y
164. Repurposing mucosal delivery devices for live attenuated tuberculosis vaccines.
Front Immunol
2023 Mar 30
Puri M, Miranda-Hernandez S, Subbian S
165. Efficacy and safety of sublingual immunotherapy for allergic rhinitis: A network meta-analysis.
Front Immunol
2023 Mar 30
Ji Z, Jiang F.
166. Single-cell analyses reveal the dynamic functions of Itgb2(+) microglia subclusters at different stages of cerebral ischemia-reperfusion injury in transient middle cerebral occlusion mice model.
Front Immunol
2023 Mar 30
Zeng F, Cao J, Hong Z
167. Evaluation of preclinical efficacy of human umbilical cord mesenchymal stem cells in ankylosing spondylitis.
Front Immunol
2023 Mar 30
Shen D, Wang Z, Wang H
168. Transformation of primary murine peritoneal mast cells by constitutive KIT activation is accompanied by loss of Cdkn2a/Arf expression.
Front Immunol
2023 Mar 30
Capellmann S, Sonntag R, Schüler H
169. A cuproptosis random forest cox score model-based evaluation of prognosis, mutation characterization, immune infiltration, and drug sensitivity in hepatocellular carcinoma.
Front Immunol
2023 Mar 30
Liu R, Liu Y, Zhang F
170. Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses.
Front Immunol
2023 Mar 30
Buscot M, Cremoni M, Graça D
171. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study.
Front Immunol
2023 Mar 30
Yang M, Lin SQ, Liu XY
172. Acute exercise and high-glucose ingestion elicit dynamic and individualized responses in systemic markers of redox homeostasis.
Front Immunol
2023 Mar 30
Thomas HJ, Ang T, Morrison DJ
173. Uncovering the significance of expanded CD8(+) large granular lymphocytes in inclusion body myositis: Insights into T cell phenotype and functional alterations, and disease severity.
Front Immunol
2023 Mar 30
McLeish E, Sooda A, Slater N
174. Fructose potentiates the protective efficiency of live Edwardsiella tarda cell vaccine.
Front Immunol
2023 Mar 30
Wang C, Peng XX, Li H.
175. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.
Front Immunol
2023 Mar 30
Hawerkamp HC, Dyer AH, Patil ND
176. Case report: Schnitzler-like syndrome without monoclonal gammopathy.
Front Immunol
2023 Mar 30
Wesselmann AS, Künstner A, Fähnrich A
177. MiR-199a-5P promotes osteogenic differentiation of human stem cells from apical papilla via targeting IFIT2 in apical periodontitis.
Front Immunol
2023 Mar 30
Hu J, Huang X, Zheng L
178. Progress in the study of biomarkers for early prediction of systemic inflammatory response syndrome after percutaneous nephrolithotomy.
Front Immunol
2023 Mar 30
Wu W, Zhang D, Jin T
179. A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells.
Front Immunol
2023 Mar 30
Donnenberg VS, Luketich JD, Sultan I
180. LRPPRC facilitates tumor progression and immune evasion through upregulation of m(6)A modification of PD-L1 mRNA in hepatocellular carcinoma.
Front Immunol
2023 Mar 30
Wang H, Tang A, Cui Y
181. Dissecting the causal effect between gut microbiota, DHA, and urate metabolism: A large-scale bidirectional Mendelian randomization.
Front Immunol
2023 Mar 30
Hou T, Dai H, Wang Q
182. Optimal combination of arsenic trioxide and copper ions to prevent autoimmunity in a murine HOCl-induced model of systemic sclerosis.
Front Immunol
2023 Mar 30
Chêne C, Rongvaux-Gaïda D, Thomas M
183. Inflammatory response triggered by avian hepatitis E virus in vivo and in vitro.
Front Immunol
2023 Mar 30
Zhang Y, Chi Z, Cui Z
184. Exosome and virus infection.
Front Immunol
2023 Mar 30
Peng Y, Yang Y, Li Y
185. Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps.
Front Immunol
2023 Mar 30
Pelaia C, Benfante A, Busceti MT
186. Cytokine concentration in peripheral blood of patients with colorectal cancer.
Front Immunol
2023 Mar 30
Li W, Chen F, Gao H
187. Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis.
Front Immunol
2023 Mar 30
Feng X, Tong W, Li J
188. mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic.
Front Immunol
2023 Mar 30
Xu Z, Fisher DE.
189. Emerging insights into the role of ferroptosis in the pathogenesis of autoimmune diseases.
Front Immunol
2023 Mar 30
Fan J, Jiang T, He D.
190. Immune cells and their related genes provide a new perspective on the common pathogenesis of ankylosing spondylitis and inflammatory bowel diseases.
Front Immunol
2023 Mar 30
Ding Y, Yang Y, Xue L.
191. Development of a dual vaccine against East Coast fever and lumpy skin disease.
Front Immunol
2023 Mar 30
Whittle L, Chapman R, Douglass N
192. Alterations in the gut virome in patients with ankylosing spondylitis.
Front Immunol
2023 Mar 30
Li C, Zhang Y, Yan Q
193. Association of atopic dermatitis with autoimmune diseases: A bidirectional and multivariable two-sample mendelian randomization study.
Front Immunol
2023 Mar 30
Zhou W, Cai J, Li Z
194. Pre-clinical models to define correlates of protection for SARS-CoV-2.
Front Immunol
2023 Mar 30
Brady C, Tipton T, Longet S
195. rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19.
Front Immunol
2023 Mar 30
Esmagambetov IB, Ryabova EI, Derkaev AA
196. Diversity of immune responses in children highly exposed to SARS-CoV-2.
Front Immunol
2023 Mar 3
Úbeda M, Maza MDC, Delgado P
197. Nur77 and PPARγ regulate transcription and polarization in distinct subsets of M2-like reparative macrophages during regenerative inflammation.
Front Immunol
2023 Mar 3
Garabuczi É, Tarban N, Fige É
198. Increased IKKϵ protein stability ensures efficient type I interferon responses in conditions of TBK1 deficiency.
Front Immunol
2023 Mar 3
Wegner J, Hunkler C, Ciupka K
199. Mechanismbased role of the intestinal microbiota in gestational diabetes mellitus: A systematic review and meta-analysis.
Front Immunol
2023 Mar 3
Yan M, Guo X, Ji G
200. Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders.
Front Immunol
2023 Mar 3
Miyamoto K, Minamino M, Kuwahara M
201. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.
Front Immunol
2023 Mar 3
Wen F, Meng F, Li X
202. Dual oxidase 1 is dispensable during Mycobacterium tuberculosis infection in mice.
Front Immunol
2023 Mar 3
Gupta T, Sarr D, Fantone K
203. Case report: Clearance of longstanding, immune-deficiency-associated, vaccine-derived polio virus infection following remdesivir therapy for chronic SARS-CoV-2 infection.
Front Immunol
2023 Mar 3
Bermingham WH, Canning B, Wilton T
204. Efficacy and safety of Iguratimod in the treatment of Ankylosing Spondylitis: A systematic review and meta-analysis of randomized controlled trials.
Front Immunol
2023 Mar 3
Long Z, Deng Y, He Q
205. Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study.
Front Immunol
2023 Mar 3
La Rosa C, Chiuppesi F, Park Y
206. Resistance of Argopecten purpuratus scallop larvae to vibriosis is associated with the front-loading of immune genes and enhanced antimicrobial response.
Front Immunol
2023 Mar 3
Jeria E, Oyanedel D, Rojas R
207. COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2.
Front Immunol
2023 Mar 3
Hisham Y, Seo SM, Kim S
208. A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults.
Front Immunol
2023 Mar 3
Xu K, Wang Z, Qin M
209. Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized mice.
Front Immunol
2023 Mar 3
Matas-Céspedes A, Lapointe JM, Elder MJ
210. Unique metabolism and protein expression signature in human decidual NK cells.
Front Immunol
2023 Mar 3
Wang P, Liang T, Zhan H
211. Neutrophils as a potential therapeutic target in Alzheimer's disease.
Front Immunol
2023 Mar 3
Aries ML, Hensley-McBain T.
212. Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma.
Front Immunol
2023 Mar 3
Wu Q, Tian R, Liu J
213. T regulatory cells metabolism: The influence on functional properties and treatment potential.
Front Immunol
2023 Mar 3
Tomaszewicz M, Ronowska A, Zieliński M
214. Intra-articular delivery of AAV vectors encoding PD-L1 attenuates joint inflammation and tissue damage in a mouse model of rheumatoid arthritis.
Front Immunol
2023 Mar 3
Li W, Sun J, Feng SL
215. Characteristics of humoral and cellular responses to coronavirus disease 2019 (COVID-19) inactivated vaccine in central China: A prospective, multicenter, longitudinal study.
Front Immunol
2023 Mar 3
Yuan Y, Xu J, Ma B
216. The role of myeloid derived suppressor cells in musculoskeletal disorders.
Front Immunol
2023 Mar 3
Ren Y, Bäcker H, Müller M
217. Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer.
Front Immunol
2023 Mar 3
Yang H, Zou X, Yang S
218. Characterization of immature ovarian teratomas through single-cell transcriptome.
Front Immunol
2023 Mar 3
Cao M, Deng Y, Deng Y
219. Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study).
Front Immunol
2023 Mar 29
Wang C, Wu Y, Liu J
220. Advances in the study of myeloid-derived suppressor cells in infectious lung diseases.
Front Immunol
2023 Mar 29
Zhang MN, Yuan YL, Ao SH.
221. Virulence capacity of different Aspergillus species from invasive pulmonary aspergillosis.
Front Immunol
2023 Mar 29
Chen B, Qian G, Yang Z
222. Non-coding RNAs derived from the foot-and-mouth disease virus genome trigger broad antiviral activity against coronaviruses.
Front Immunol
2023 Mar 29
Rodríguez-Pulido M, Calvo-Pinilla E, Polo M
223. SARS-CoV-2 spike antibody concentration in gamma globulin products from high-prevalence COVID-19 countries are transmitted to X-linked agammaglobulinemia patients.
Front Immunol
2023 Mar 29
Raphael A, Shamriz O, Tvito A
224. Photobiomodulation ameliorates inflammatory parameters in fibroblast-like synoviocytes and experimental animal models of rheumatoid arthritis.
Front Immunol
2023 Mar 29
Ryu JH, Park J, Kim BY
225. Proteomics: Potential techniques for discovering the pathogenesis of connective tissue diseases-interstitial lung disease.
Front Immunol
2023 Mar 29
Wu Y, Li Y, Luo Y
226. The crosslinks between ferroptosis and autophagy in asthma.
Front Immunol
2023 Mar 29
Lv X, Tang W, Qin J
227. Challenges and opportunities in analyzing and modeling peptide presentation by HLA-II proteins.
Front Immunol
2023 Mar 29
ElAbd H, Bacher P, Tholey A
228. The macrophages regulate intestinal motility dysfunction through the PGE2 Ptger3 axis during Klebsiella pneumonia sepsis.
Front Immunol
2023 Mar 29
Yao H, Fu X, Xu Q
229. The impact of chronic rhinosinusitis on COVID-19 risk and outcomes: A systematic review and meta-analysis.
Front Immunol
2023 Mar 29
Reda A, Lashin BI, Alaaraj MM
230. Tracking of activated cTfh cells following sequential influenza vaccinations reveals transcriptional profile of clonotypes driving a vaccine-induced immune response.
Front Immunol
2023 Mar 29
Currenti J, Simmons J, Oakes J
231. Telomerase reverse transcriptase and neurodegenerative diseases.
Front Immunol
2023 Mar 29
Yu X, Liu MM, Zheng CY
232. γδ T cells recruitment and local proliferation in brain parenchyma benefit anti-neuroinflammation after cerebral microbleeds.
Front Immunol
2023 Mar 29
Su X, Yang S, Li Y
233. Directional preference for glioblastoma cancer cell membrane encapsulated nanoparticle population: A probabilistic approach for cancer therapeutics.
Front Immunol
2023 Mar 29
Khan S, Khan MWA, Sherwani S
234. Exosomes, MDSCs and Tregs: A new frontier for GVHD prevention and treatment.
Front Immunol
2023 Mar 29
Hess NJ, Kink JA, Hematti P.
235. LDC7559 inhibits microglial activation and GSDMD-dependent pyroptosis after subarachnoid hemorrhage.
Front Immunol
2023 Mar 29
Cai W, Wu Z, Lai J
236. Cardiac and vascular complications in lupus: Is there a role for sex?
Front Immunol
2023 Mar 29
Corker A, Learmonth M, Patrick DM
237. Progress in the clinical application of immune checkpoint inhibitors in small cell lung cancer.
Front Immunol
2023 Mar 29
He J, Hu Q.
238. Thromboinflammatory response is increased in pancreas transplant alone versus simultaneous pancreas-kidney transplantation and early pancreas graft thrombosis is associated with complement activation.
Front Immunol
2023 Mar 29
Rydenfelt K, Kjøsen G, Horneland R
239. Identification of immunodiagnostic blood biomarkers associated with spinal cord injury severity.
Front Immunol
2023 Mar 29
Li J, Liu X, Wang J
240. Transcriptomic analysis reveals shared gene signatures and molecular mechanisms between obesity and periodontitis.
Front Immunol
2023 Mar 29
Cai Y, Zuo X, Zuo Y
241. Identification and validation of hub genes in drug induced acute kidney injury basing on integrated transcriptomic analysis.
Front Immunol
2023 Mar 29
Deng YX, Liu K, Qiu QX
242. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells.
Front Immunol
2023 Mar 29
Thapaliya M, Ali H.
243. Immunometabolic interference between cancer and COVID-19.
Front Immunol
2023 Mar 29
Consonni FM, Durante B, Manfredi M
244. Deciphering the role of QPCTL in glioma progression and cancer immunotherapy.
Front Immunol
2023 Mar 29
Liu Y, Lu S, Sun Y
245. Integrated summary of immunogenicity of polatuzumab vedotin in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Front Immunol
2023 Mar 29
Dere RC, Beardsley RL, Lu D
246. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease.
Front Immunol
2023 Mar 29
Zhang X, Chao P, Zhang L
247. HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development.
Front Immunol
2023 Mar 29
Elnaggar JH, Huynh VO, Lin D
248. Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody.
Front Immunol
2023 Mar 28
Bai Y, Li W, Yan C
249. Induction of antigen specific intrahepatic CD8+ T cell responses by a secreted heat shock protein based gp96-Ig-PfCA malaria vaccine.
Front Immunol
2023 Mar 28
Padula L, Fisher E, Wijayalath W
250. CD226 identifies functional CD8(+)T cells in the tumor microenvironment and predicts a better outcome for human gastric cancer.
Front Immunol
2023 Mar 28
Huang H, Huang Z, Ge J
251. Lipoteichoic acid of Streptococcus gordonii as a negative regulator of human dendritic cell activation.
Front Immunol
2023 Mar 28
Kim SK, Im J, Ko EB
252. Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma.
Front Immunol
2023 Mar 28
Yan K, Zhang D, Chen Y
253. Multicenter, single-arm, phase II study (CAP) of radiotherapy plus liposomal irinotecan followed by camrelizumab and anti-angiogenic treatment in advanced solid tumors.
Front Immunol
2023 Mar 28
Shen J, Yan J, Du J
254. Combined analysis of bulk and single-cell RNA sequencing reveals novel natural killer cell-related prognostic biomarkers for predicting immunotherapeutic response in hepatocellular carcinoma.
Front Immunol
2023 Mar 28
Zhang K, Yuan E.
255. The effect of combined knockdowns of Attacins on survival and bacterial load in Tenebrio molitor.
Front Immunol
2023 Mar 28
Keshavarz M, Zanchi C, Rolff J.
256. Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy.
Front Immunol
2023 Mar 28
Zhang Y, Feng X, Chen J
257. The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9.
Front Immunol
2023 Mar 28
Möller A, Jauch-Speer SL, Gandhi S
258. Gene signature and prediction model of the mitophagy-associated immune microenvironment in renal ischemia-reperfusion injury.
Front Immunol
2023 Mar 28
Chen RY, Li DW, Xie H
259. Investigating iron intake in risk of progression from islet autoimmunity to type 1 diabetes: The diabetes autoimmunity study in the young.
Front Immunol
2023 Mar 28
Elhassan S, Dong F, Buckner T
260. Antimicrobial peptides´ immune modulation role in intracellular bacterial infection.
Front Immunol
2023 Mar 28
Duarte-Mata DI, Salinas-Carmona MC.
261. Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs.
Front Immunol
2023 Mar 28
von Gunten S, Schneider C, Imamovic L
262. The potential value of Notch1 and DLL1 in the diagnosis and prognosis of patients with active TB.
Front Immunol
2023 Mar 28
Xie J, Chen Y, Chen S
263. Transcriptional regulation of innate lymphoid cells and T cells by aryl hydrocarbon receptor.
Front Immunol
2023 Mar 28
Helm EY, Zhou L.
264. Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV.
Front Immunol
2023 Mar 28
Dirajlal-Fargo S, Strah M, Ailstock K
265. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation.
Front Immunol
2023 Mar 28
Dumolard L, Aspord C, Marche PN
266. Targeting chemoattractant chemokine (C-C motif) ligand 2 derived from astrocytes is a promising therapeutic approach in the treatment of neuromyelitis optica spectrum disorders.
Front Immunol
2023 Mar 28
Wang Y, Bian J, Yao M
267. Immunotherapy efficacy predictive tool for lung adenocarcinoma based on neural network.
Front Immunol
2023 Mar 28
Li W, Fu S, Gao X
268. N6-methyladenosine-methylomic landscape of lung tissues of mice with chronic obstructive pulmonary disease.
Front Immunol
2023 Mar 28
Hu T, Xu L, Jiang M
269. Impact of BCG vaccination on the repertoire of human γδ T cell receptors.
Front Immunol
2023 Mar 28
Xia M, Blazevic A, Fiore-Gartland A
270. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.
Front Immunol
2023 Mar 28
Liu Y, Shi Z, Zheng J
271. Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes.
Front Immunol
2023 Mar 28
Ciechomska M, Roszkowski L, Burakowski T
272. Current research into A20 mediation of allergic respiratory diseases and its potential usefulness as a therapeutic target.
Front Immunol
2023 Mar 28
Liu Y, Xu K, Yao Y
273. Characterization of TLR1 and expression profiling of TLR signaling pathway related genes in response to Aeromonas hydrophila challenge in hybrid yellow catfish (Pelteobagrus fulvidraco ♀ × P. vachelli ♂).
Front Immunol
2023 Mar 28
Guo S, Gao W, Zeng M
274. The transdermal cream of Formestane anti-breast cancer by controlling PI3K-Akt pathway and the tumor immune microenvironment.
Front Immunol
2023 Mar 28
Gao L, Zhu L, Shen C
275. Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy.
Front Immunol
2023 Mar 28
Chiu CY, Schou MD, McMahon JH
276. Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China.
Front Immunol
2023 Mar 27
Zou M, Liu H, Liu H
277. FGL2 deficiency alleviates maternal inflammation-induced blood-brain barrier damage by blocking PI3K/NF-κB mediated endothelial oxidative stress.
Front Immunol
2023 Mar 27
Huang L, Zhan D, Xing Y
278. Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation.
Front Immunol
2023 Mar 27
Huang T, Wu W, Wu J
279. Predictive short/long-term efficacy biomarkers and resistance mechanisms of CD19-directed CAR-T immunotherapy in relapsed/refractory B-cell lymphomas.
Front Immunol
2023 Mar 27
Xu H, Li N, Wang G
280. Alpha-linolenic acid pretreatment alleviates NETs-induced alveolar macrophage pyroptosis by inhibiting pyrin inflammasome activation in a mouse model of sepsis-induced ALI/ARDS.
Front Immunol
2023 Mar 27
Liu C, Zhou Y, Tu Q
281. New insights into the germline genes and CDR3 repertoire of the TCRβ chain in Chiroptera.
Front Immunol
2023 Mar 27
Zhou H, Li J, Zhou D
282. Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.
Front Immunol
2023 Mar 27
Cui S, Cao S, Chen Q
283. Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders.
Front Immunol
2023 Mar 27
John J, Chen SMY, Woolaver RA
284. Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab.
Front Immunol
2023 Mar 27
Lin YT, Li CF, Wu HC
285. Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma.
Front Immunol
2023 Mar 27
Sun L, Liu Z, Wu Z
286. Effects of supplemental octanoate on hepatic lipid metabolism, serum biochemical indexes, antioxidant capacity and inflammation-related genes expression of large yellow croaker (Larimichthys crocea) fed with high soybean oil diet.
Front Immunol
2023 Mar 27
Zhao M, Zhang Z, Liu Y
287. Impaired tolerance to the autoantigen LL-37 in acute coronary syndrome.
Front Immunol
2023 Mar 27
Chernomordik F, Cercek B, Zhou J
288. The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus.
Front Immunol
2023 Mar 27
Banos A, Thomas K, Garantziotis P
289. The serum IgG antibody level as a biomarker for clinical outcome in patients with cerebral sparganosis after treatment.
Front Immunol
2023 Mar 27
Xiang H, Wang J, Tan D
290. A new hope? Possibilities of therapeutic IgA antibodies in the treatment of inflammatory lung diseases.
Front Immunol
2023 Mar 27
Bohländer F.
291. Role of increased neutrophil extracellular trap formation on acute kidney injury in COVID-19 patients.
Front Immunol
2023 Mar 27
Kim IS, Kim DH, Lee HW
292. Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily.
Front Immunol
2023 Mar 27
Zaitseva O, Anany M, Wajant H
293. Adaptive immune response to BNT162b2 mRNA vaccine in immunocompromised adolescent patients.
Front Immunol
2023 Mar 27
Bader G, Itan M, Edry-Botzer L
294. Deciphering the complete human-monkeypox virus interactome: Identifying immune responses and potential drug targets.
Front Immunol
2023 Mar 27
Kataria R, Kaur S, Kaundal R.
295. Analysis of necroptosis-related prognostic genes and immune infiltration in idiopathic pulmonary fibrosis.
Front Immunol
2023 Mar 27
Chen H, Xia Z, Qing B
296. Advances in CRISPR/Cas gene therapy for inborn errors of immunity.
Front Immunol
2023 Mar 27
Liu X, Li G, Liu Y
297. Role of NLRP3 in the pathogenesis and treatment of gout arthritis.
Front Immunol
2023 Mar 27
Liu YR, Wang JQ, Li J.
298. Granulosa cell-derived miR-379-5p regulates macrophage polarization in polycystic ovarian syndrome.
Front Immunol
2023 Mar 24
Salehi R, Asare-Werehene M, Wyse BA
299. Construction and immunogenicity of a trypsin-independent porcine epidemic diarrhea virus variant.
Front Immunol
2023 Mar 24
Li M, Zhang Y, Fang Y
300. A computer vision approach for analyzing label free leukocyte trafficking dynamics on a microvascular mimetic.
Front Immunol
2023 Mar 24
Ahmad SD, Cetin M, Waugh RE
301. Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab.
Front Immunol
2023 Mar 24
Tischer-Zimmermann S, Bonifacius A, Santamorena MM
302. Targeting NK-1R attenuates renal fibrosis via modulating inflammatory responses and cell fate in chronic kidney disease.
Front Immunol
2023 Mar 24
Zhu E, Liu Y, Zhong M
303. Identification of cancer-associated fibroblasts subtypes in prostate cancer.
Front Immunol
2023 Mar 24
Pan J, Ma Z, Liu B
304. Erratum: Rapid generation of TCR and CD8αβ transgenic virus specific T cells for immunotherapy of leukemia.
Front Immunol
2023 Mar 24
Frontiers Production Office.
305. Damage-associated molecular patterns and sensing receptors based molecular subtypes in malignant pleural mesothelioma and implications for immunotherapy.
Front Immunol
2023 Mar 24
Liu Z, Wan R, Bai H
306. Risk stratification based on DNA damage-repair-related signature reflects the microenvironmental feature, metabolic status and therapeutic response of breast cancer.
Front Immunol
2023 Mar 24
Li C, Yu S, Chen J
307. Assessing the association of leukocyte telomere length with ankylosing spondylitis and rheumatoid arthritis: A bidirectional Mendelian randomization study.
Front Immunol
2023 Mar 24
Wei D, Jiang Y, Cheng J
308. A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma.
Front Immunol
2023 Mar 24
Chang W, Li H, Ou W
309. Non-viral TRAC-knocked-in CD19(KI)CAR-T and gp350(KI)CAR-T cells tested against Burkitt lymphomas with type 1 or 2 EBV infection: In vivo cellular dynamics and potency.
Front Immunol
2023 Mar 24
Braun T, Pruene A, Darguzyte M
310. Development of a broadly active influenza intranasal vaccine adjuvanted with self-assembled particles composed of mastoparan-7 and CpG.
Front Immunol
2023 Mar 24
Ontiveros-Padilla L, Batty CJ, Hendy DA
311. Combining preclinical tools and models to unravel tumor complexity: Jump into the next dimension.
Front Immunol
2023 Mar 24
Miserocchi G, Bocchini M, Cortesi M
312. Cellular and humoral immunogenicity of the COVID-19 vaccine and COVID-19 disease severity in individuals with immunodeficiency.
Front Immunol
2023 Mar 24
Murray CE, O'Brien C, Alamin S
313. Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer.
Front Immunol
2023 Mar 24
Kowash RR, Akbay EA.
314. Advanced immunophenotyping: A powerful tool for immune profiling, drug screening, and a personalized treatment approach.
Front Immunol
2023 Mar 24
Preglej T, Brinkmann M, Steiner G
315. Immune-related adverse events correlate with the efficacy of PD-1 inhibitors combination therapy in advanced cholangiocarcinoma patients: A retrospective cohort study.
Front Immunol
2023 Mar 24
Zhang Y, Wang X, Li Y
316. Arenaviruses: Old viruses present new solutions for cancer therapy.
Front Immunol
2023 Mar 24
Stachura P, Stencel O, Lu Z
317. Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells.
Front Immunol
2023 Mar 24
Ismail NI.
318. Clinical implications of gut microbiota and cytokine responses in coronavirus disease prognosis.
Front Immunol
2023 Mar 24
Seong H, Kim JH, Han YH
319. Total neoadjuvant treatment and PD-1/PD-L1 checkpoint inhibitor in locally advanced rectal cancer.
Front Immunol
2023 Mar 24
Xiao W, Luo H, Yao Y
320. Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma.
Front Immunol
2023 Mar 24
Koh YW, Park B, Jung SH
321. Immune and ionic mechanisms mediating the effect of dexamethasone in severe COVID-19.
Front Immunol
2023 Mar 24
Chimote AA, Alshwimi AO, Chirra M
322. The dysregulation of leukemia inhibitory factor and its implications for endometriosis pathophysiology.
Front Immunol
2023 Mar 23
Zutautas KB, Sisnett DJ, Miller JE
323. Modeling the effects of cigarette smoke extract on influenza B virus infections in mice.
Front Immunol
2023 Mar 23
Chavez JR, Yao W, Dulin H
324. Macrophage-infectivity potentiator of Trypanosoma cruzi (TcMIP) is a new pro-type 1 immuno-stimulating protein for neonatal human cells and vaccines in mice.
Front Immunol
2023 Mar 23
Radwanska M, de Lemos Esteves F, Linsen L
325. Monoacylglycerol lipase regulates macrophage polarization and cancer progression in uveal melanoma and pan-cancer.
Front Immunol
2023 Mar 23
Tan Y, Pan J, Deng Z
326. Optimal LC-MS metabolomic profiling reveals emergent changes to monocyte metabolism in response to lipopolysaccharide.
Front Immunol
2023 Mar 23
Leacy E, Batten I, Sanelli L
327. Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses.
Front Immunol
2023 Mar 23
Jossi SE, Arcuri M, Alshayea A
328. Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma.
Front Immunol
2023 Mar 23
Szczygieł A, Węgierek-Ciura K, Wróblewska A
329. Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysis.
Front Immunol
2023 Mar 23
Qin H, Liu F, Zhang Y
330. Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic.
Front Immunol
2023 Mar 23
de Sèze J, Maillart E, Gueguen A
331. Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine.
Front Immunol
2023 Mar 23
Qin J, Jeon JH, Xu J
332. Diabetes mellitus induces a novel inflammatory network involving cancer progression: Insights from bioinformatic analysis and in vitro validation.
Front Immunol
2023 Mar 23
Tan Y, Kang J, Li H
333. The m(6)A methylation landscape, molecular characterization and clinical relevance in prostate adenocarcinoma.
Front Immunol
2023 Mar 23
Li C, Peng D, Gan Y
334. PathwayKO: An integrated platform for deciphering the systems-level signaling pathways.
Front Immunol
2023 Mar 23
Ai H, Meng F, Ai Y.
335. Pattern-recognition receptors in endometriosis: A narrative review.
Front Immunol
2023 Mar 23
Guo B, Chen JH, Zhang JH
336. Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1(-) stem cell-like T cells over PD-1(+) T cells curbing tumor progression.
Front Immunol
2023 Mar 23
Del Rio ML, de Juan CY, Roncador G
337. Add fuel to the fire: Inflammation and immune response in lung cancer combined with COVID-19.
Front Immunol
2023 Mar 23
Ai Y, Wang H, Zheng Q
338. C1q and central nervous system disorders.
Front Immunol
2023 Mar 23
Zhang W, Chen Y, Pei H.
339. Erratum: Overcoming immune resistance with radiation therapy in prostate cancer.
Front Immunol
2023 Mar 23
Frontiers Production Office.
340. Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment.
Front Immunol
2023 Mar 23
Wang F, Lu S, Zhou X
341. Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies.
Front Immunol
2023 Mar 23
Senturk ZN, Akdag I, Deniz B
342. Anti-tumor memory CD4 and CD8 T-cells quantified by bulk T-cell receptor (TCR) clonal analysis.
Front Immunol
2023 Mar 23
Gao Y, Bergman I.
343. Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets.
Front Immunol
2023 Mar 23
Zheng Z, Li X, Nie K
344. Single-cell protein activity analysis reveals a novel subpopulation of chondrocytes and the corresponding key master regulator proteins associated with anti-senescence and OA progression.
Front Immunol
2023 Mar 23
Guang Z, Min Z, Jun-Tan L
345. Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis.
Front Immunol
2023 Mar 23
Glover A, Zhang Z, Shannon-Lowe C.
346. A new insight into the impact of systemic lupus erythematosus on oocyte and embryo development as well as female fertility.
Front Immunol
2023 Mar 23
Mao R, Wang X, Long R
347. Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors.
Front Immunol
2023 Mar 23
Gan L, Chen H, Liu X
348. Psychobiotic Lactobacillus plantarum JYLP-326 relieves anxiety, depression, and insomnia symptoms in test anxious college via modulating the gut microbiota and its metabolism.
Front Immunol
2023 Mar 23
Zhu R, Fang Y, Li H
349. An immune-related gene signature predicts the 28-day mortality in patients with sepsis.
Front Immunol
2023 Mar 23
Peng Y, Wu Q, Liu H
350. Immune activation and exhaustion marker expression on T-cell subsets in ART-treated adolescents and young adults with perinatal HIV-1 infection as correlates of viral persistence.
Front Immunol
2023 Mar 23
Huang Y, Dhummakupt A, Khetan P
351. Glycan masking in vaccine design: Targets, immunogens and applications.
Front Immunol
2023 Mar 23
Martina CE, Crowe JE Jr, Meiler J.
352. Towards a consensus definition of immune exclusion in cancer.
Front Immunol
2023 Mar 22
Tiwari A, Oravecz T, Dillon LA
353. Longitudinal analysis of immunocyte responses and inflammatory cytokine profiles in SFTSV-infected rhesus macaques.
Front Immunol
2023 Mar 22
Li YH, Huang WW, He WQ
354. CD300b regulates intestinal inflammation and promotes repair in colitis.
Front Immunol
2023 Mar 22
Avlas S, Kassis H, Itan M
355. Human seminal plasma stimulates the migration of CD11c+ mononuclear phagocytes to the apical side of the colonic epithelium without altering the junctional complexes in an ex vivo human intestinal model.
Front Immunol
2023 Mar 22
Baratella M, Iannone V, Cavarelli M
356. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
Front Immunol
2023 Mar 22
Bodle J, Vandenberg K, Laurie K
357. Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review.
Front Immunol
2023 Mar 22
Zielińska A, Eder P, Karczewski J
358. Immune transgene-dependent myocarditis in macaques after systemic administration of adeno-associated virus expressing human acid alpha-glucosidase.
Front Immunol
2023 Mar 22
Hordeaux J, Ramezani A, Tuske S
359. GPX3 and GSTT1 as biomarkers related to oxidative stress during renal ischemia reperfusion injuries and their relationship with immune infiltration.
Front Immunol
2023 Mar 22
Pei J, Tian X, Yu C
360. Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.
Front Immunol
2023 Mar 22
Li X, Zhou J, Wang X
361. Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications.
Front Immunol
2023 Mar 22
Liu Y, Tong H, He F
362. The emerging role of neutrophil extracellular traps in endometritis.
Front Immunol
2023 Mar 22
Li H, Liu L, Wang J
363. Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19.
Front Immunol
2023 Mar 22
Lee CM, Choe PG, Kang CK
364. Efficacy and safety of dietary polyphenols in rheumatoid arthritis: A systematic review and meta-analysis of 47 randomized controlled trials.
Front Immunol
2023 Mar 22
Long Z, Xiang W, He Q
365. Global-feature of autoimmune glomerulonephritis using proteomic analysis of laser capture microdissected glomeruli.
Front Immunol
2023 Mar 22
Dong J, Zheng F, Liu F
366. Protective effects of Bacillus licheniformis on growth performance, gut barrier functions, immunity and serum metabolome in lipopolysaccharide-challenged weaned piglets.
Front Immunol
2023 Mar 22
Yu X, Dai Z, Cao G
367. Microglial immune regulation by epigenetic reprogramming through histone H3K27 acetylation in neuroinflammation.
Front Immunol
2023 Mar 22
Huang M, Malovic E, Ealy A
368. Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern.
Front Immunol
2023 Mar 22
Ruhl L, Kühne JF, Beushausen K
369. DDX58 expression promotes inflammation and growth arrest in Sertoli cells by stabilizing p65 mRNA in patients with Sertoli cell-only syndrome.
Front Immunol
2023 Mar 22
Sun H, Yang Z, Teng Z
370. Functions of exosomal non-coding RNAs to the infection with Mycobacterium tuberculosis.
Front Immunol
2023 Mar 22
Wang J, Li Y, Wang N
371. Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets.
Front Immunol
2023 Mar 22
Barbarroja N, López-Montilla MD, Cuesta-López L
372. An updated review of the immunological mechanisms of keloid scars.
Front Immunol
2023 Mar 22
Lee CC, Tsai CH, Chen CH
373. Maternal provisions in type 1 diabetes: Evidence for both protective & pathogenic potential.
Front Immunol
2023 Mar 22
Strachan E, Clemente-Casares X, Tsai S.
374. Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1(I249/M280)-expressing retina.
Front Immunol
2023 Mar 22
Church KA, Rodriguez D, Mendiola AS
375. Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection.
Front Immunol
2023 Mar 21
Frontiers Production Office.
376. Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters.
Front Immunol
2023 Mar 21
King HAD, Dussupt V, Mendez-Rivera L
377. Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments.
Front Immunol
2023 Mar 21
Niu L, Liang D, Ling Q
378. Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
Front Immunol
2023 Mar 21
Zhang W, Liu L, Xiao X
379. Erratum: Virus-like particles are efficient tools for boosting mRNA-induced antibodies.
Front Immunol
2023 Mar 21
Frontiers Production Office.
380. Proteotranscriptomic analyses reveal distinct interferon-beta signaling pathways and therapeutic targets in choroidal neovascularization.
Front Immunol
2023 Mar 21
Hu Y, Qi S, Zhuang H
381. VIGET: A web portal for study of vaccine-induced host responses based on Reactome pathways and ImmPort data.
Front Immunol
2023 Mar 21
Brunson T, Sanati N, Huffman A
382. Development and validation of a flow cytometry antibody test for Lawsonia intracellularis.
Front Immunol
2023 Mar 21
Baldasso DZ, Guizzo JA, Dazzi CC
383. The immediate adverse drug reactions induced by ShenMai Injection are mediated by thymus-derived T cells and associated with RhoA/ROCK signaling pathway.
Front Immunol
2023 Mar 21
Jiang S, Sun B, Zhang Y
384. Active regression model for clinical grading of COVID-19.
Front Immunol
2023 Mar 21
Sh Y, Dong J, Chen Z
385. Orf virus DNA prime-protein boost strategy is superior to adenovirus-based vaccination in mice and sheep.
Front Immunol
2023 Mar 21
Wang Y, Sun S, Zhao K
386. Identification of key genes and imbalance of immune cell infiltration in immunoglobulin A associated vasculitis nephritis by integrated bioinformatic analysis.
Front Immunol
2023 Mar 21
Jia X, Zhu H, Jiang Q
387. Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation.
Front Immunol
2023 Mar 21
Ballou C, Barton F, Payne EH
388. Abnormal thrombosis and neutrophil activation increase hospital-acquired sacral pressure injuries and morbidity in COVID-19 patients.
Front Immunol
2023 Mar 21
Narang J, Jatana S, Ponti AK
389. A flagellin-conjugate protein induces dual NLRC4- and NLRP3-inflammasome activation which modulates inflammatory cytokine secretion from macrophages.
Front Immunol
2023 Mar 21
Lin YJ, Jamin A, Wolfheimer S
390. Inflammation markers and the risk of hypertension in people living with HIV.
Front Immunol
2023 Mar 21
Ou-Yang H, Fu HY, Luo Y
391. The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors.
Front Immunol
2023 Mar 21
Del Baldo G, Del Bufalo F, Pinacchio C
392. PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.
Front Immunol
2023 Mar 21
van Amerongen RA, Tuit S, Wouters AK
393. Single-cell RNA analysis to identify five cytokines signaling in immune-related genes for melanoma survival prognosis.
Front Immunol
2023 Mar 21
Pu Z, Zhao Q, Chen J
394. Autoimmune encephalitis with mGluR5 antibodies: A case series from China and review of the literature.
Front Immunol
2023 Mar 21
Guo K, Liu X, Gong X
395. The effect of herbal medicine in innate immunity to Candida albicans.
Front Immunol
2023 Mar 21
Bao MY, Li M, Bu QR
396. Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue.
Front Immunol
2023 Mar 21
Bensussen A, Torres-Magallanes JA, Roces de Álvarez-Buylla E.
397. Case report: Rapid development of amyloid A amyloidosis in temporal arteritis with SAA1.3 allele; An unusual case of intestinal amyloidosis secondary to temporal arteritis.
Front Immunol
2023 Mar 21
Yoshida S, Matsumoto H, Temmoku J
398. Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma.
Front Immunol
2023 Mar 21
Willems M, Scherpereel A, Wasielewski E
399. SOCS3 as a potential driver of lung metastasis in colon cancer patients.
Front Immunol
2023 Mar 21
Li X, Yang Z, Chen B
400. PCSK9 regulates the efficacy of immune checkpoint therapy in lung cancer.
Front Immunol
2023 Mar 21
Gao X, Yi L, Jiang C
401. CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis.
Front Immunol
2023 Mar 21
Bandara G, Falduto GH, Luker A
402. Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics.
Front Immunol
2023 Mar 20
Wang D, Wu C, Chen S
403. Time series clustering of T cell subsets dissects heterogeneity in immune reconstitution and clinical outcomes among MUD-HCT patients receiving ATG or PTCy.
Front Immunol
2023 Mar 20
Leserer S, Graf T, Franke M
404. Exploration of the common genetic landscape of COVID-19 and male infertility.
Front Immunol
2023 Mar 20
Chen Y, Sun T, Liu K
405. Disruption of endosomal trafficking with EGA alters TLR9 cytokine response in human plasmacytoid dendritic cells.
Front Immunol
2023 Mar 20
Wiest MJ, Gu C, Ham H
406. Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis.
Front Immunol
2023 Mar 20
Satrapova V, Sparding N, Genovese F
407. The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies.
Front Immunol
2023 Mar 20
Daei Sorkhabi A, Mohamed Khosroshahi L, Sarkesh A
408. Characterization of dysbiosis of the conjunctival microbiome and nasal microbiome associated with allergic rhinoconjunctivitis and allergic rhinitis.
Front Immunol
2023 Mar 20
Wang Y, Li X, Gu S
409. Comprehensive analysis, immune, and cordycepin regulation for SOX9 expression in pan-cancers and the matched healthy tissues.
Front Immunol
2023 Mar 20
Liu S, Yang L, Fu J
410. Hormonal and inflammatory modulatory effects of hesperidin in hyperthyroidism-modeled rats.
Front Immunol
2023 Mar 20
Ashry M, Askar H, Obiedallah MM
411. Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications.
Front Immunol
2023 Mar 20
Liu Y, Zheng Y, Yang Y
412. Identification of immunotherapy and chemotherapy-related molecular subtypes in colon cancer by integrated multi-omics data analysis.
Front Immunol
2023 Mar 20
Zhu J, Kong W, Huang L
413. Mechanism of HIFs in osteoarthritis.
Front Immunol
2023 Mar 20
Zhang XA, Kong H.
414. Multi-faceted role of LRP1 in the immune system.
Front Immunol
2023 Mar 20
Sizova O, John LS, Ma Q
415. Protection from COVID-19 disease in hamsters vaccinated with subunit SARS-CoV-2 S1 mucosal vaccines adjuvanted with different adjuvants.
Front Immunol
2023 Mar 20
Sui Y, Andersen H, Li J
416. Potentials of saponins-based adjuvants for nasal vaccines.
Front Immunol
2023 Mar 20
Chen K, Wang N, Zhang X
417. Abscopal effect triggered by radiation sequential mono-immunotherapy resulted in a complete remission of PMMR sigmoid colon cancer.
Front Immunol
2023 Mar 20
Zhou P, Wang Y, Qin S
418. Rodent models of postherpetic neuralgia: How far have we reached?
Front Immunol
2023 Mar 20
Ou M, Chen J, Yang S
419. Architecture of the SARS-CoV-2-specific T cell repertoire.
Front Immunol
2023 Mar 20
Zornikova KV, Sheetikov SA, Rusinov AY
420. Mucosal-associated invariant T cells in hematological malignancies: Current knowledge, pending questions.
Front Immunol
2023 Mar 20
Treiner E.
421. The role of immunometabolism in macrophage polarization and its impact on acute lung injury/acute respiratory distress syndrome.
Front Immunol
2023 Mar 20
Wang L, Wang D, Zhang T
422. Role of the PADI family in inflammatory autoimmune diseases and cancers: A systematic review.
Front Immunol
2023 Mar 20
Zhu C, Liu C, Chai Z.
423. Case report: Myocarditis in congenital STAT1 gain-of function.
Front Immunol
2023 Mar 20
Staels F, Roosens W, Giovannozzi S
424. Ankylosing spondylitis and glaucoma in European population: A Mendelian randomization study.
Front Immunol
2023 Mar 20
Li S, Chen M, Zhang Q
425. Effective differentiation of double negative thymocytes requires high fidelity replication of mitochondrial DNA in an age dependent manner.
Front Immunol
2023 Mar 20
Limper CB, Bondah N, Zhu D
426. Case report: Preliminary response to tislelizumab plus S-1 in patients with metastatic gallbladder carcinoma: A report of five cases and a literature review.
Front Immunol
2023 Mar 20
Zhang Y, Liu Y, Liu J
427. Abundance of ACVR1B transcript is elevated during septic conditions: Perspectives obtained from a hands-on reductionist investigation.
Front Immunol
2023 Mar 20
Preechanukul A, Yimthin T, Tandhavanant S
428. Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease.
Front Immunol
2023 Mar 20
Zhang N, Tian X, Yan T
429. Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections.
Front Immunol
2023 Mar 2
Yang J, Won G, Baek JY
430. Comparison of humoral and cellular immune responses between ChAd-BNT heterologous vaccination and BNT-BNT homologous vaccination following the third BNT dose: A prospective cohort study.
Front Immunol
2023 Mar 2
Sim W, Kang H, Jung J
431. Skeletal myotube-derived extracellular vesicles enhance itaconate production and attenuate inflammatory responses of macrophages.
Front Immunol
2023 Mar 2
Yamaguchi A, Maeshige N, Yan J
432. Megakaryocytes respond during sepsis and display innate immune cell behaviors.
Front Immunol
2023 Mar 2
Frydman GH, Ellett F, Jorgensen J
433. Antiphospholipid antibodies in patients with stroke during COVID-19: A role in the signaling pathway leading to platelet activation.
Front Immunol
2023 Mar 2
Capozzi A, Riitano G, Recalchi S
434. C-reactive protein - My perspective on its first half century, 1930-1982.
Front Immunol
2023 Mar 2
Kushner I.
435. YOUPI: Your powerful and intelligent tool for segmenting cells from imaging mass cytometry data.
Front Immunol
2023 Mar 2
Scuiller Y, Hemon P, Le Rochais M
436. Systematic integration of machine learning algorithms to develop immune escape-related signatures to improve clinical outcomes in lung adenocarcinoma patients.
Front Immunol
2023 Mar 2
Wang T, Huang L, Zhou J
437. Knowledge mapping of global trends for myasthenia gravis development: A bibliometrics analysis.
Front Immunol
2023 Mar 2
Jiang F, Su Y, Chang T.
438. Integrated analysis from multicentre studies identities m7G-related lncRNA-derived molecular subtypes and risk stratification systems for gastric cancer.
Front Immunol
2023 Mar 2
Ma M, Li J, Zeng Z
439. Comparison of NK alloreactivity prediction models based on KIR-MHC interactions in haematopoietic stem cell transplantation.
Front Immunol
2023 Mar 2
Dhuyser A, Remen T, Pérès M
440. Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case study.
Front Immunol
2023 Mar 2
Walker RI, Bourgeois AL.
441. The colonic interleukin-19 aggravates the dextran sodium sulfate/stress-induced comorbidities due to colitis and anxiety.
Front Immunol
2023 Mar 2
Li Q, Meng F, Ma X
442. Immunogenic cell death triggered by impaired deubiquitination in multiple myeloma relies on dysregulated type I interferon signaling.
Front Immunol
2023 Mar 2
Waad Sadiq Z, Brioli A, Al-Abdulla R
443. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
Front Immunol
2023 Mar 2
Xu L, Gao X, Xing J
444. Use of Streptococcus salivarius K12 in supporting the mucosal immune function of active young subjects: A randomised double-blind study.
Front Immunol
2023 Mar 2
Bertuccioli A, Gervasi M, Annibalini G
445. Identification of genes related to immune enhancement caused by heterologous ChAdOx1-BNT162b2 vaccines in lymphocytes at single-cell resolution with machine learning methods.
Front Immunol
2023 Mar 2
Li J, Huang F, Ma Q
446. Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV.
Front Immunol
2023 Mar 2
Wang Y, Li J, Zhang W
447. A novel liver zonation phenotype-associated molecular classification of hepatocellular carcinoma.
Front Immunol
2023 Mar 2
Zhang T, Gu J, Wang X
448. CAR-iNKT cells targeting clonal TCRVβ chains as a precise strategy to treat T cell lymphoma.
Front Immunol
2023 Mar 2
Rowan AG, Ponnusamy K, Ren H
449. Endothelial Protein kinase D1 is a major regulator of post-traumatic hyperinflammation.
Front Immunol
2023 Mar 2
Schönfelder J, Seibold T, Morawe M
450. Lymphocyte-to-C reactive protein ratio as novel inflammatory marker for predicting outcomes in hemodialysis patients: A multicenter observational study.
Front Immunol
2023 Mar 2
Chen X, Guo W, Diao Z
451. The role of hyaluronan in renal cell carcinoma.
Front Immunol
2023 Mar 2
Jin C, Zong Y.
452. The application of Interleukin-2 family cytokines in tumor immunotherapy research.
Front Immunol
2023 Mar 2
Zhou Y, Quan G, Liu Y
453. Nocardia rubra cell-wall skeleton activates an immune response in cervical tissue via stimulating FPR3 to enhance dendritic cell-mediated Th1 differentiation.
Front Immunol
2023 Mar 2
Guo Q, Chen W, Sun J
454. Beyond energy balance regulation: The underestimated role of adipose tissues in host defense against pathogens.
Front Immunol
2023 Mar 2
Barthelemy J, Bogard G, Wolowczuk I.
455. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
Front Immunol
2023 Mar 17
Wang X, Bai Y, Zhang F
456. Cholesterol sulfate limits neutrophil recruitment and gut inflammation during mucosal injury.
Front Immunol
2023 Mar 17
Morino K, Kunimura K, Sugiura Y
457. Role and mechanism of fibroblast-activated protein-α expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis.
Front Immunol
2023 Mar 17
Wang Z, Wang J, Lan T
458. Antibodies to SARS-CoV-2 in follicular fluids and their association with assisted reproduction.
Front Immunol
2023 Mar 17
Chillon TS, Weiss G, Demircan K
459. Advances in the development of antivirals for rotavirus infection.
Front Immunol
2023 Mar 17
Jiang L, Tang A, Song L
460. Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients.
Front Immunol
2023 Mar 17
Qian J, Li R, Chen Z
461. Histone acetylation-related IncRNA: Potential biomarkers for predicting prognosis and immune response in lung adenocarcinoma, and distinguishing hot and cold tumours.
Front Immunol
2023 Mar 17
Li R, Qiu T, Zhou Q
462. Hyaluronan breakdown by snake venom hyaluronidases: From toxins delivery to immunopathology.
Front Immunol
2023 Mar 17
Silva de França F, Tambourgi DV.
463. Deficient leptin receptor signaling in T cells of human SLE.
Front Immunol
2023 Mar 17
Liu T, Zheng M, Jia L
464. BTG2 and SerpinB5, a novel gene pair to evaluate the prognosis of lung adenocarcinoma.
Front Immunol
2023 Mar 17
Yang W, Wei C, Cheng J
465. Advances in the potential roles of Cullin-RING ligases in regulating autoimmune diseases.
Front Immunol
2023 Mar 17
Zhang X, Liu Y, Zhang T
466. Integrated analysis to identify the prognostic and immunotherapeutic roles of coagulation-associated gene signature in clear cell renal cell carcinoma.
Front Immunol
2023 Mar 17
Yin G, Tian T, Ji X
467. Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond.
Front Immunol
2023 Mar 17
Zhao Y, Du J, Shen X.
468. Anti-cyclooxygenase, anti-glycation, and anti-skin aging effect of Dendrobium officinale flowers' aqueous extract and its phytochemical validation in aging.
Front Immunol
2023 Mar 17
Zhou H, Zhou L, Li B
469. Hemorrhage complications in obstetric antiphospholipid syndrome: Risk factors and association with adverse pregnancy outcomes.
Front Immunol
2023 Mar 17
Luo Y, Jin J, Yan Y
470. Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma.
Front Immunol
2023 Mar 17
Zhang X, Zhuge J, Liu J
471. Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis-associated aplastic anemia.
Front Immunol
2023 Mar 17
Zhang X, Yang W, Yang D
472. Treatment of refractory lupus nephritis using leflunomide: A prospective study.
Front Immunol
2023 Mar 17
Zhang S, Chen Y, Chen X
473. Fueling the flames of colon cancer - does CRP play a direct pro-inflammatory role?
Front Immunol
2023 Mar 17
Køstner AH, Fuglestad AJ, Georgsen JB
474. Epithelioid hemangioendothelioma of the retroperitoneal giant type treated with Toripalimab: A case report.
Front Immunol
2023 Mar 17
Bu Y, Peng L, Liu M
475. Control of myeloid cell functions by nociceptors.
Front Immunol
2023 Mar 17
Hanč P, Messou MA, Wang Y
476. Impact of chronic alcohol exposure on conventional and regulatory murine T cell subsets.
Front Immunol
2023 Mar 17
Paterson CW, Gutierrez MB, Coopersmith CM
477. Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory Burkitt's lymphoma with TP53 mutations.
Front Immunol
2023 Mar 17
Zhang Q, Zhu X, Liu B
478. The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis.
Front Immunol
2023 Mar 17
Duarte-Silva E, Meuth SG, Peixoto CA.
479. Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma.
Front Immunol
2023 Mar 17
Umeyama Y, Taniguchi H, Gyotoku H
480. Varicella Zoster Virus infects mucosal associated Invariant T cells.
Front Immunol
2023 Mar 17
Purohit SK, Corbett AJ, Slobedman B
481. Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target.
Front Immunol
2023 Mar 17
Yang Z, Nicholson SE, Cancio TS
482. The current understanding of the immune landscape relative to radiotherapy across tumor types.
Front Immunol
2023 Mar 16
Iliadi C, Verset L, Bouchart C
483. LAMP3 expression in the liver is involved in T cell activation and adaptive immune regulation in hepatitis B virus infection.
Front Immunol
2023 Mar 16
Wang Z, Wang X, Jin R
484. Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy.
Front Immunol
2023 Mar 16
Yang J, Zeng L, Chen R
485. Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer.
Front Immunol
2023 Mar 16
Zhong Y, Zheng C, Zhang W
486. COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study.
Front Immunol
2023 Mar 16
Lodde GC, Krefting F, Placke JM
487. Isolated anti-Ro52 identifies a severe subset of Sjögren's syndrome patients.
Front Immunol
2023 Mar 16
Lee AYS, Putty T, Lin MW
488. Molecular characterization and expression analysis of B-cell lymphoma-2 in Trachinotus ovatus and its role in apoptotic process.
Front Immunol
2023 Mar 16
Cao Z, Yang X, Li T
489. CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment.
Front Immunol
2023 Mar 16
Han R, Li J, Hony J
490. IgA2 immune complexes selectively promote inflammation by human CD103(+) dendritic cells.
Front Immunol
2023 Mar 16
Mes L, Steffen U, Chen HJ
491. Analysis of potential immune-related genes involved in the pathogenesis of ischemia-reperfusion injury following liver transplantation.
Front Immunol
2023 Mar 16
Guo J, Han S, Chen Q
492. Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years.
Front Immunol
2023 Mar 16
Ruggiero R, Balzano N, Di Napoli R
493. DNA lipid nanoparticle vaccine targeting outer surface protein C affords protection against homologous Borrelia burgdorferi needle challenge in mice.
Front Immunol
2023 Mar 16
Pfeifle A, Thulasi Raman SN, Lansdell C
494. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells.
Front Immunol
2023 Mar 16
Lunardelli VAS, Almeida BDS, Apostolico JS
495. Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer.
Front Immunol
2023 Mar 16
Zhang M, Li X, Zhang Q
496. Galectin-9 promotes natural killer cells activity via interaction with CD44.
Front Immunol
2023 Mar 16
Rahmati A, Bigam S, Elahi S.
497. Treg-specific deletion of the phosphatase SHP-1 impairs control of inflammation in vivo.
Front Immunol
2023 Mar 16
Gu Q, Tung KS, Lorenz UM.
498. Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study.
Front Immunol
2023 Mar 16
Alt M, Wolf S, van de Sand L
499. TR score: A noninvasive model to predict histological stages in patients with primary biliary cholangitis.
Front Immunol
2023 Mar 16
Tu Z, Wang Y, Wang Y
500. Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer.
Front Immunol
2023 Mar 16
Xu X, Ding C, Zhong H
501. Perivascular adipose tissue promotes vascular dysfunction in murine lupus.
Front Immunol
2023 Mar 16
Shi H, Goo B, Kim D
502. Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation.
Front Immunol
2023 Mar 16
Pérez-Diego M, Angelina A, Martín-Cruz L
503. The impact of hepatocyte-specific deletion of hypoxia-inducible factors on the development of polymicrobial sepsis with focus on GR and PPARα function.
Front Immunol
2023 Mar 16
Vanderhaeghen T, Timmermans S, Eggermont M
504. A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma.
Front Immunol
2023 Mar 16
Pichler R, Siska PJ, Tymoszuk P
505. Comprehensive analysis of m6A RNA methylation modification patterns and the immune microenvironment in osteoarthritis.
Front Immunol
2023 Mar 16
Liu Z, Liu H, Li D
506. A humanized anti-human adenovirus 55 monoclonal antibody with good neutralization ability.
Front Immunol
2023 Mar 16
Chen L, Lu J, Yue J
507. Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment.
Front Immunol
2023 Mar 16
Lv J, Jiang Z, Yuan J
508. Giardia duodenalis-induced G0/G1 intestinal epithelial cell cycle arrest and apoptosis involve activation of endoplasmic reticulum stress in vitro.
Front Immunol
2023 Mar 15
Yu S, Zhao H, Qin X
509. Establishing a human bone marrow single cell reference atlas to study ageing and diseases.
Front Immunol
2023 Mar 15
Lee NYS, Li M, Ang KS
510. Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients.
Front Immunol
2023 Mar 15
Seree-Aphinan C, Ratanapokasatit Y, Suchonwanit P
511. Parasitic nematode secreted phospholipase A(2) suppresses cellular and humoral immunity by targeting hemocytes in Drosophila melanogaster.
Front Immunol
2023 Mar 15
Parks SC, Okakpu OK, Azizpor P
512. Molecules promoting circulating clusters of cancer cells suggest novel therapeutic targets for treatment of metastatic cancers.
Front Immunol
2023 Mar 15
Rozenberg JM, Buzdin AA, Mohammad T
513. Erratum: Monocyte biology conserved across species: Functional insights from cattle.
Front Immunol
2023 Mar 15
Frontiers Production Office.
514. Mapping the SLP76 interactome in T cells lacking each of the GRB2-family adaptors reveals molecular plasticity of the TCR signaling pathway.
Front Immunol
2023 Mar 15
Ruminski K, Celis-Gutierrez J, Jarmuzynski N
515. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing.
Front Immunol
2023 Mar 15
Chi H, Zhao S, Yang J
516. Assessment of local and systemic signature of eosinophilic esophagitis (EoE) in children through multi-omics approaches.
Front Immunol
2023 Mar 15
Adel-Patient K, Campeotto F, Grauso M
517. Prospects for targeting ACKR1 in cancer and other diseases.
Front Immunol
2023 Mar 15
Crawford KS, Volkman BF.
518. SARS-CoV-2 antibody responses associate with sex, age and disease severity in previously uninfected people admitted to hospital with COVID-19: An ISARIC4C prospective study.
Front Immunol
2023 Mar 15
Parker E, Thomas J, Roper KJ
519. PlGF/FLT-1 deficiency leads to reduced STAT3-C/EBPβ signaling and aberrant polarization in decidual macrophages during early spontaneous abortion.
Front Immunol
2023 Mar 15
Chang R, Dai J, Wang L
520. Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential.
Front Immunol
2023 Mar 15
Eleftheriotis G, Tsounis EP, Aggeletopoulou I
521. The role of NOD-like receptors in innate immunity.
Front Immunol
2023 Mar 15
Almeida-da-Silva CLC, Savio LEB, Coutinho-Silva R
522. Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 cases.
Front Immunol
2023 Mar 15
Janela R, Ishii N, Castel M
523. Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option.
Front Immunol
2023 Mar 15
Asija S, Chatterjee A, Goda JS
524. Expression patterns of eight RNA-modified regulators correlating with immune infiltrates during the progression of osteoarthritis.
Front Immunol
2023 Mar 15
Chen Z, Wang W, Hua Y.
525. Bioinformatics analysis reveals the potential role of matrix metalloproteinases in immunity and urolithiasis.
Front Immunol
2023 Mar 15
Hong SY, Jiang HC, Xu WC
526. The relationship between autophagy and PD-L1 and their role in antitumor therapy.
Front Immunol
2023 Mar 15
Cui Y, Shi J, Cui Y
527. Application of a JEG-3 organoid model to study HLA-G function in the trophoblast.
Front Immunol
2023 Mar 15
Zhuang BM, Cao DD, Liu XF
528. The clusterin connectome: Emerging players in chondrocyte biology and putative exploratory biomarkers of osteoarthritis.
Front Immunol
2023 Mar 15
Kovács P, Pushparaj PN, Takács R
529. Construction and immunogenicity of an mRNA vaccine against chikungunya virus.
Front Immunol
2023 Mar 15
Liu J, Lu X, Li X
530. Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered.
Front Immunol
2023 Mar 15
López-Cortés LF, Saborido-Alconchel A, Trujillo-Rodríguez M
531. Innate-like T lymphocytes in chronic liver disease.
Front Immunol
2023 Mar 15
Papanastasatou M, Verykokakis M.
532. Adrenergic receptor signaling regulates the CD40-receptor mediated anti-tumor immunity.
Front Immunol
2023 Mar 15
Singh A, Ranjan A.
533. Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.
Front Immunol
2023 Mar 15
Peng Z, Wang J, Tong S
534. Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice.
Front Immunol
2023 Mar 15
Li X, Liu J, Li W
535. SnoRNA and lncSNHG: Advances of nucleolar small RNA host gene transcripts in anti-tumor immunity.
Front Immunol
2023 Mar 15
Xiao H, Feng X, Liu M
536. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
Front Immunol
2023 Mar 15
Deng M, Aberle MR, van Bijnen AAJHM
537. Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19.
Front Immunol
2023 Mar 15
Thiriard A, Meyer B, Eberhardt CS
538. Overlapping cytokines in H. pylori infection and gastric cancer: A tandem meta-analysis.
Front Immunol
2023 Mar 15
Yu B, Xiang L, Peppelenbosch MP
539. Alternative splicing derived invertebrate variable lymphocyte receptor displays diversity and specificity in immune system of crab Eriocheir sinensis.
Front Immunol
2023 Mar 14
Xu Y, Yang Y, Zheng J
540. Cytosolic DNA sensors and glial responses to endogenous DNA.
Front Immunol
2023 Mar 14
Suptela AJ, Marriott I.
541. Breast milk microRNAs: Potential players in oral tolerance development.
Front Immunol
2023 Mar 14
Ahlberg E, Al-Kaabawi A, Thune R
542. Effects of the circulating environment of COVID-19 on platelet and neutrophil behavior.
Front Immunol
2023 Mar 14
Fields AT, Andraska EA, Kaltenmeier C
543. Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge.
Front Immunol
2023 Mar 14
Gary EN, Tursi NJ, Warner BM
544. Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC.
Front Immunol
2023 Mar 14
Wu H, Feng J, Zhong W
545. Aerosolized nicotine from e-cigarettes alters gene expression, increases lung protein permeability, and impairs viral clearance in murine influenza infection.
Front Immunol
2023 Mar 14
Maishan M, Sarma A, Chun LF
546. Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer.
Front Immunol
2023 Mar 14
Chen F, Yang J, Guo Y
547. Porphyromonas gingivalis regulates atherosclerosis through an immune pathway.
Front Immunol
2023 Mar 14
Ruan Q, Guan P, Qi W
548. First in man study: Bcl-Xl_42-CAF(®)09b vaccines in patients with locally advanced prostate cancer.
Front Immunol
2023 Mar 14
Mørk SK, Kongsted P, Westergaard MCW
549. ROS-AMPK/mTOR-dependent enterocyte autophagy is involved in the regulation of Giardia infection-related tight junction protein and nitric oxide levels.
Front Immunol
2023 Mar 14
Wu J, Yang Y, Liu L
550. Effect of monovalency on anti-contactin-1 IgG4.
Front Immunol
2023 Mar 14
Taieb G, Jentzer A, Vegezzi E
551. The impact of cytoreductive nephrectomy on survival outcomes in patients with metastatic renal cell carcinoma receiving immunotherapy: An evidence-based analysis of comparative outcomes.
Front Immunol
2023 Mar 14
Li KP, Chen SY, Wang CY
552. Epigenetic immune monitoring for COVID-19 disease course prognosis.
Front Immunol
2023 Mar 14
Samans B, Rosselló Chornet M, Rosselló Chornet A
553. Causal associations between modifiable risk factors and pancreatitis: A comprehensive Mendelian randomization study.
Front Immunol
2023 Mar 14
Mao X, Mao S, Sun H
554. Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes.
Front Immunol
2023 Mar 14
Nanjireddy PM, Olejniczak SH, Buxbaum NP.
555. Erratum: CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
Front Immunol
2023 Mar 14
Frontiers Production Office.
556. Role of stem cell derivatives in inflammatory diseases.
Front Immunol
2023 Mar 14
Yang Y, Peng Y, Li Y
557. Emerging of a new CD3(+)CD31(H)CD184(+) tang cell phenothype in Sjögren's syndrome induced by microencapsulated human umbilical cord matrix-derived multipotent stromal cells.
Front Immunol
2023 Mar 14
Montanucci P, Bistoni O, Antonucci M
558. Design of a multi-epitopic vaccine against Epstein-Barr virus via computer-based methods.
Front Immunol
2023 Mar 14
Larijani A, Kia-Karimi A, Roostaei D.
559. A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies.
Front Immunol
2023 Mar 14
Sabetta E, Noviello M, Sciorati C
560. Intratumor microbiota as a novel potential prognostic indicator in mesothelioma.
Front Immunol
2023 Mar 14
Pentimalli F, Krstic-Demonacos M, Costa C
561. Association between the overall burden of comorbidity and Ct values among the older patients with Omicron infection: Mediated by inflammation.
Front Immunol
2023 Mar 14
Wang M, Mi H, Li N
562. Cyclophosphamide-induced seizures in a patient with neuropsychiatric systemic lupus erythematosus (NPSLE): A case report.
Front Immunol
2023 Mar 14
Zhang L, Shi Y, Zhang J
563. Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II.
Front Immunol
2023 Mar 14
Ellison M, Mangiola M, Marrari M
564. Recombinant viral hemorrhagic septicemia virus with rearranged genomes as vaccine vectors to protect against lethal betanodavirus infection.
Front Immunol
2023 Mar 14
Souto S, Mérour E, Le Coupanec A
565. Identification and validation of IgG N-glycosylation biomarkers of esophageal carcinoma.
Front Immunol
2023 Mar 14
Pan H, Wu Z, Zhang H
566. Bioengineered bacterial outer membrane vesicles encapsulated Polybia-mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy.
Front Immunol
2023 Mar 14
Ren C, Li Y, Cong Z
567. Low-dose administration of prednisone has a good effect on the treatment of prolonged hematologic toxicity post-CD19 CAR-T cell therapy.
Front Immunol
2023 Mar 14
Wang J, Zhang M, Lyu H
568. Transmission of stimulus-induced epigenetic changes through cell division is coupled to continuous transcription factor activity.
Front Immunol
2023 Mar 14
Sun S, Aguirre-Gamboa R, Barreiro LB.
569. N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms.
Front Immunol
2023 Mar 14
Chen L, Gao Y, Xu S
570. Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients.
Front Immunol
2023 Mar 13
Gaete-Argel A, Saavedra-Alarcón V, Sauré D
571. The unfolding story of dying tumor cells during cancer treatment.
Front Immunol
2023 Mar 13
He S, Huang Q, Cheng J.
572. T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis.
Front Immunol
2023 Mar 13
Zheng C, Shi Y, Zou Y.
573. Multifaceted involvements of Paneth cells in various diseases within intestine and systemically.
Front Immunol
2023 Mar 13
Cui C, Wang X, Li L
574. Role of the inflammasome in insulin resistance and type 2 diabetes mellitus.
Front Immunol
2023 Mar 13
Lu S, Li Y, Qian Z
575. UcTCRdb: An unconventional T cell receptor sequence database with online analysis functions.
Front Immunol
2023 Mar 13
Dou Y, Shan S, Zhang J.
576. Trained immunity: A "new" weapon in the fight against infectious diseases.
Front Immunol
2023 Mar 13
Dagenais A, Villalba-Guerrero C, Olivier M.
577. Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer.
Front Immunol
2023 Mar 13
Guo Q, Zhao L, Yan N
578. Chronic CD27-CD70 costimulation promotes type 1-specific polarization of effector Tregs.
Front Immunol
2023 Mar 13
Bowakim-Anta N, Acolty V, Azouz A
579. Erratum: Mechanisms of extracellular vesicle-mediated immune evasion in melanoma.
Front Immunol
2023 Mar 13
Frontiers Production Office.
580. Resolvin D1/N-formyl peptide receptor 2 ameliorates paclitaxel-induced neuropathic pain through the activation of IL-10/Nrf2/HO-1 pathway in mice.
Front Immunol
2023 Mar 13
Su CJ, Zhang JT, Zhao FL
581. Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China.
Front Immunol
2023 Mar 13
Li M, Zhao C, Zhao Y
582. Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients.
Front Immunol
2023 Mar 13
Sans-de San Nicolàs L, Figueras-Nart I, García-Jiménez I
583. From a cell model to a fish trial: Immunomodulatory effects of heat-killed Lactiplantibacillus plantarum as a functional ingredient in aquafeeds for salmonids.
Front Immunol
2023 Mar 13
Rocha SDC, Lei P, Morales-Lange B
584. Exploring SARS-CoV-2 and Plasmodium falciparum coinfection in human erythrocytes.
Front Immunol
2023 Mar 13
López-Farfán D, Irigoyen N, Gómez-Díaz E.
585. Modulation of low-dose ozone and LPS exposed acute mouse lung inflammation by IF1 mediated ATP hydrolysis inhibitor, BTB06584.
Front Immunol
2023 Mar 13
Singh P, Aulakh GK.
586. Sirtuin-dependent metabolic and epigenetic regulation of macrophages during tuberculosis.
Front Immunol
2023 Mar 13
Zhang K, Sowers ML, Cherryhomes EI
587. P2RX7 signaling drives the differentiation of Th1 cells through metabolic reprogramming for aerobic glycolysis.
Front Immunol
2023 Mar 13
de Salles ÉM, Raeder PL, Angeli CB
588. Cross-sectional association between systemic metal concentrations and immune markers in patients with total joint arthroplasty.
Front Immunol
2023 Mar 13
Peterson SM, O'Byrne TJ, Brennan PC
589. Amount of antigen, T follicular helper cells and affinity of founder cells shape the diversity of germinal center B cells: A computational study.
Front Immunol
2023 Mar 13
Garg AK, Mitra T, Schips M
590. Fibrinogen-like protein 1 promotes liver-resident memory T-cell exhaustion in hepatocellular carcinoma.
Front Immunol
2023 Mar 13
Yang C, Qian Q, Zhao Y
591. Safety and efficacy of radiotherapy/chemoradiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: A systematic review and meta-analysis.
Front Immunol
2023 Mar 13
Wu J, Ni T, Deng R
592. Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study.
Front Immunol
2023 Mar 13
Cao G, Hua D, Li J
593. Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA.
Front Immunol
2023 Mar 13
Celesti F, Gatta A, Shallak M
594. KW2449 ameliorates collagen-induced arthritis by inhibiting RIPK1-dependent necroptosis.
Front Immunol
2023 Mar 13
Wang Q, Ye Q, Xi X
595. Vitamin B12 attenuates leukocyte inflammatory signature in COVID-19 via methyl-dependent changes in epigenetic markings.
Front Immunol
2023 Mar 13
Cassiano LMG, Cavalcante-Silva V, Oliveira MS
596. A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations.
Front Immunol
2023 Mar 13
Kharouf F, Eviatar T, Braun M
597. Neutrophil extracellular traps in tumor progression and immunotherapy.
Front Immunol
2023 Mar 13
Yan M, Gu Y, Sun H
598. The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study.
Front Immunol
2023 Mar 13
Wang Y, Qiao Y, Huo Y
599. Non-coding RNA alterations in extracellular vesicles from bronchoalveolar lavage fluid contribute to mechanical ventilation-induced pulmonary fibrosis.
Front Immunol
2023 Mar 13
Tang R, Hu Y, Mei S
600. A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer.
Front Immunol
2023 Mar 13
Luo Y, Ye Y, Chen Y
601. Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism.
Front Immunol
2023 Mar 13
Shafi AM, Végvári Á, Zubarev RA
602. Development of multi-epitope vaccines against the monkeypox virus based on envelope proteins using immunoinformatics approaches.
Front Immunol
2023 Mar 13
Tan C, Zhu F, Pan P
603. Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation.
Front Immunol
2023 Mar 13
Dhakal B, Li CMY, Ramezanpour M
604. The role of Th-17 cells and IL-17 in the metastatic spread of breast cancer: As a means of prognosis and therapeutic target.
Front Immunol
2023 Mar 13
Shibabaw T, Teferi B, Ayelign B.
605. Erratum: Single-cell gene expression analysis of cryopreserved equine bronchoalveolar cells.
Front Immunol
2023 Mar 13
Frontiers Production Office.
606. Impaired response of memory Treg to high density lipoproteins is associated with intermediate/high cardiovascular disease risk in persons with HIV.
Front Immunol
2023 Mar 10
Atehortua L, Baig M, Morris J
607. SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity.
Front Immunol
2023 Mar 10
Yang G, Wang J, Sun P
608. Nlrp12 deficiency alters gut microbiota and ameliorates Fas(lpr) -mediated systemic autoimmunity in male mice.
Front Immunol
2023 Mar 10
Abdelhamid L, Mao J, Cabana-Puig X
609. Deficiency of endothelial FGFR1 signaling via upregulation of ROCK2 activity aggravated ALI/ARDS.
Front Immunol
2023 Mar 10
Deng Y, Huang X, Hu Y
610. Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment.
Front Immunol
2023 Mar 10
Surendran A, Jamalkhah M, Poutou J
611. Genetically predicted levels of folate, vitamin B(12), and risk of autoimmune diseases: A Mendelian randomization study.
Front Immunol
2023 Mar 10
Yang H, Song J, Li A
612. Experimental mouse models for translational human cancer research.
Front Immunol
2023 Mar 10
Zhou Y, Xia J, Xu S
613. Next-generation humanized NSG-SGM3 mice are highly susceptible to Staphylococcus aureus infection.
Front Immunol
2023 Mar 10
Hung S, Kasperkowitz A, Kurz F
614. Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children.
Front Immunol
2023 Mar 10
Tiono AB, Palacpac NMQ, Bougouma EC
615. Adaptive and innate immune pathogenesis of bullous pemphigoid: A review.
Front Immunol
2023 Mar 10
Yan T, Zhang Z.
616. An experimental medicine decipher of a minimum correlate of cellular immunity: Study protocol for a double-blind randomized controlled trial.
Front Immunol
2023 Mar 10
Kalimuddin S, Chan YFZ, Sessions OM
617. Culture density influences the functional phenotype of human macrophages.
Front Immunol
2023 Mar 10
Ruder AV, Temmerman L, van Dommelen JMA
618. Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression.
Front Immunol
2023 Mar 10
He X, Guo Y, Yu C
619. Cervical cancer immune infiltration microenvironment identification, construction of immune scores, assisting patient prognosis and immunotherapy.
Front Immunol
2023 Mar 10
Yao S, Zhao L, Chen S
620. The many faces of parasite calreticulin.
Front Immunol
2023 Mar 10
Esperante D, Flisser A, Mendlovic F.
621. A multiscale mechanistic model of human dendritic cells for in-silico investigation of immune responses and novel therapeutics discovery.
Front Immunol
2023 Mar 10
Aghamiri SS, Puniya BL, Amin R
622. Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity.
Front Immunol
2023 Mar 10
Chi H, Yang J, Peng G
623. From birth to death: The hardworking life of Paneth cell in the small intestine.
Front Immunol
2023 Mar 10
Cui C, Wang F, Zheng Y
624. The role of the complosome in health and disease.
Front Immunol
2023 Mar 10
Xiao F, Guo J, Tomlinson S
625. Alterations of the fecal and vaginal microbiomes in patients with systemic lupus erythematosus and their associations with immunological profiles.
Front Immunol
2023 Mar 10
Ling Z, Cheng Y, Gao J
626. Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients.
Front Immunol
2023 Mar 10
Geng R, Tang H, You T
627. Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy.
Front Immunol
2023 Mar 10
Yang C, Li D, Ko CN
628. Zetomipzomib (KZR-616) attenuates lupus in mice via modulation of innate and adaptive immune responses.
Front Immunol
2023 Mar 10
Muchamuel T, Fan RA, Anderl JL
629. Mucosal-associated invariant T cells in patients with axial spondyloarthritis.
Front Immunol
2023 Mar 10
van der Meer RG, Spoorenberg A, Brouwer E
630. Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis.
Front Immunol
2023 Mar 10
Ma Y, Zhang P, Bao Y
631. Development and validation of a prognostic model based on immune variables to early predict severe cases of SARS-CoV-2 Omicron variant infection.
Front Immunol
2023 Mar 1
Lu T, Man Q, Yu X
632. SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID study.
Front Immunol
2023 Mar 1
Geldof J, Truyens M, Sabino J
633. Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysis.
Front Immunol
2023 Mar 1
Mou L, Pu Z, Luo Y
634. Strategies for optimizing CITE-seq for human islets and other tissues.
Front Immunol
2023 Mar 1
Colpitts SJ, Budd MA, Monajemi M
635. "From molecular to clinic": The pivotal role of CDC42 in pathophysiology of human papilloma virus related cancers and a correlated sensitivity of afatinib.
Front Immunol
2023 Mar 1
Wei E, Li J, Anand P
636. Post-translational modifications confer amphotericin B resistance in Candida krusei isolated from a neutropenic patient.
Front Immunol
2023 Mar 1
Zhang L, Xiao J, Du M
637. The extracellular microenvironment in immune dysregulation and inflammation in retinal disorders.
Front Immunol
2023 Mar 1
Biasella F, Plössl K, Baird PN
638. Immune complex-induced haptokinesis in human non-classical monocytes.
Front Immunol
2023 Mar 1
Preuß SL, Oehrl S, Zhang H
639. The transient receptor potential channels in rheumatoid arthritis: Need to pay more attention.
Front Immunol
2023 Mar 1
Niu M, Zhao F, Chen R
640. Revisiting targeted therapy and immunotherapy for advanced cholangiocarcinoma.
Front Immunol
2023 Mar 1
Du J, Lv X, Zhang Z
641. Hemophilia A subjects with an intron-22 gene inversion mutation show CD4(+) T-effector responses to multiple epitopes in FVIII.
Front Immunol
2023 Mar 1
Gunasekera D, Vir P, Karim AF
642. Multi-omics approach to study the dual effects of novel proteins on the intestinal health of juvenile largemouth bass (Micropterus salmoides) under an alternate feeding strategy.
Front Immunol
2023 Mar 1
Li L, Wang Y, Huang Y
643. IgA-producing B cells in lung homeostasis and disease.
Front Immunol
2023 Mar 1
Bertrand Y, Sánchez-Montalvo A, Hox V
644. Abnormally primed CD8 T cells: The Achilles' heel of CHB.
Front Immunol
2023 Mar 1
Chen X, Liu X, Jiang Y
645. Relationship between gut microbiota and rheumatoid arthritis: A bibliometric analysis.
Front Immunol
2023 Mar 1
Dong Y, Yao J, Deng Q
646. Effects of anti-inflammatory therapies on glycemic control in type 2 diabetes mellitus.
Front Immunol
2023 Mar 1
Li D, Zhong J, Zhang Q
647. Clonal relationships of memory B cell subsets in autoimmune mice.
Front Immunol
2023 Mar 1
Aranburu A, Engström E, Gerasimcik N
648. In silico analysis of single nucleotide polymorphism (rs34377097) of TBXA2R gene and pollen induced bronchial asthma susceptibility in West Bengal population, India.
Front Immunol
2023 Mar 1
Ganai I, Saha I, Banerjee P
649. Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma.
Front Immunol
2023 Mar 1
Liang L, Wang X, Huang S
650. Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians.
Front Immunol
2023 Mar 1
Zhou H, Luo Q, Wu W
651. Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients.
Front Immunol
2023 Mar 1
Daamen AR, Wang H, Bachali P
652. Chitosan oligosaccharide improves ovarian granulosa cells inflammation and oxidative stress in patients with polycystic ovary syndrome.
Front Immunol
2023 Mar 1
Xie Q, Hong W, Li Y
653. Tongue sole creatine kinases function as DAMP and activate antimicrobial immunity via TLR2.
Front Immunol
2023 Mar 1
Li X, Jiang S, Sun L.
Copyright © 2021-2024 上海牛马人生物科技有限公司 沪ICP备 2022007390号-2